Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1050.Time spend outdoors in summer,49767,0.0651276977484428,0.0239247987614405,0.0182350921760194,0.112020303320866,0.0064905156895174
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1060.Time spent outdoors in winter,47620,-0.00324228854368555,0.0263791360772614,-0.0549453952551179,0.0484608181677468,0.902178797118838
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1070.Time spent watching television (TV),50555,0.0902496210351365,0.0236794038514329,0.0438379894863281,0.136661252583945,0.000138607803696437
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1080.Time spent using computer,47631,-0.0293740955632249,0.0235425332667072,-0.0755174607659711,0.0167692696395213,0.212155099006752
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X1090.Time spent driving,44963,0.0220995665349229,0.0257488753558668,-0.028368229162576,0.0725673622324218,0.390754263358098
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1160.Sleep duration,51603,-0.00297387283927656,0.0215804935438975,-0.0452716401853156,0.0393238945067625,0.890396730353466
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35859,-0.0223541883164216,0.0204940050990816,-0.0625224383106215,0.0178140616777783,0.275411542311025
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35859,-0.0104860977705742,0.0226899063439328,-0.0549583142046824,0.033986118663534,0.643988948252341
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35859,-0.0122500532177894,0.0239560180259934,-0.0592038485487365,0.0347037421131577,0.609117361899086
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35859,-0.0419068990445674,0.0245100474263653,-0.0899465920002434,0.00613279391110862,0.0873484680641293
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35859,-0.0186552317388415,0.0251936600753186,-0.0680348054864659,0.0307243420087829,0.459036826799541
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35859,-0.0281739935178745,0.0660239087537711,-0.157580854675266,0.101232867639517,0.669592944317078
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35859,-0.0524291869276292,0.0790145168621233,-0.207297639977391,0.102439266122132,0.507006697399982
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35859,0.00235750419599594,0.0398144570041678,-0.0756788315321729,0.0803938399241647,0.952784670305536
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35859,0.0456227405833866,0.0308109801798566,-0.0147667805691323,0.106012261735906,0.138721955249509
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35859,0.0183448535027329,0.0206317015690778,-0.0220932815726596,0.0587829885781253,0.373947348879869
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35859,0.0360679217023663,0.0325569077844129,-0.0277436175550829,0.0998794609598155,0.2679666065281
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35859,-0.0115787008548266,0.0153627600361168,-0.0416897105256156,0.0185323088159624,0.451062090988119
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35859,-0.00341625244695411,0.0210943387015624,-0.0447611563020165,0.0379286514081083,0.871348828659914
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35859,0.111533487682636,0.0333888043297372,0.0460914311963508,0.176975544168921,0.000840660246261447
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35859,0.0127009389735917,0.031349476426444,-0.0487440348222384,0.0741459127694219,0.685386260832086
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35859,-0.00327780254102191,0.0380887938284776,-0.077931838444838,0.0713762333627942,0.931423579186374
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35859,0.00617823719205472,0.0372460022012797,-0.0668239271224535,0.0791804015065629,0.868258746086016
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35859,0.0121227415135618,0.0234577383243955,-0.0338544256022535,0.058099908629377,0.605318001804415
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35859,0.0153506249779958,0.0229833541208116,-0.0296967490987949,0.0603979990547865,0.504217473782988
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35859,-0.0198599702659114,0.0255183748814201,-0.0698759850334949,0.0301560445016721,0.436440197636426
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120040.Fatigue severity over the past week,35866,0.0459808887523866,0.04256174329787,-0.0374401281114386,0.129401905616212,0.280029441998416
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120041.Waking unrefreshed severity over the past week,35869,0.0321058483062249,0.0419652696444637,-0.050146080196924,0.114357776809374,0.444262092800083
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120042.Cognitive symptoms severity over the past week,35868,0.0138020647693783,0.0458717301540961,-0.07610652633265,0.103710655871407,0.763511641732836
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120098.Mobility problems today,35870,-0.00366989748388516,0.0484335528767612,-0.098599661122337,0.0912598661545667,0.93960273767666
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120099.Self-care problems today,35870,0.00253827426284945,0.072800820042612,-0.14015133302067,0.145227881546369,0.972187540244956
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120100.Problems doing usual activities,35870,-0.029427589612624,0.0472227002306247,-0.121984082064649,0.0631289028394005,0.53319488140217
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120101.Pain or discomfort today,35870,-0.0537214759301889,0.0421967341722264,-0.136427074907753,0.0289841230473748,0.203016442237293
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120102.Anxiety or depression today,35870,0.0268823086075131,0.0537514487799602,-0.0784705310012088,0.132235148216235,0.617003972148722
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120103.Scale to indicate how health is today,35853,-0.00483969417435653,0.00671195694118222,-0.0179951297790737,0.00831574143036062,0.470898544086592
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35854,0.0029619233813646,0.0526538018663793,-0.100239528276739,0.106163375039468,0.955141975202137
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35852,0.0354222807230076,0.055837224435573,-0.0740186791707155,0.144863240616731,0.525849809979825
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35858,-0.0441580671593813,0.0429713861374325,-0.128381983988749,0.0400658496699864,0.304164932810493
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35863,-0.0352690048879633,0.0437690349340075,-0.121056313358618,0.0505183035826914,0.420385665569689
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35862,-0.0332679025183818,0.0628751080554918,-0.156503114307146,0.0899673092703821,0.596744724501482
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120109.Feeling bad about self over the last two weeks,35845,0.00235613471247524,0.0593753313251838,-0.114019514684885,0.118731784109835,0.968347708174492
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120110.Trouble concentrating over the last two weeks,35865,-0.0123399269882397,0.056735088301241,-0.123540700058672,0.0988608460821927,0.827824194737578
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35858,0.00302071419894961,0.0811879430147842,-0.156107654110027,0.162149082507927,0.97032142859736
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35825,0.142353540678312,0.1127812330026,-0.0786976760067843,0.363404757363408,0.206914173566293
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33106,-0.0216175703078684,0.0593239891421268,-0.137892589026437,0.0946574484107001,0.715577591388903
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49135,0.117008287376222,0.052813584471375,0.0134936618123266,0.220522912940117,0.0267369632313829
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47941,0.0661470883153443,0.031317182614827,0.0047654103902833,0.127528766240405,0.0346849990839864
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1289.Cooked vegetable intake,50687,-0.0207553265222397,0.0224775201866344,-0.0648112660880432,0.0233006130435637,0.35581851161733
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49871,-0.0563857936702479,0.0231240387872163,-0.101708909693192,-0.011062677647304,0.0147603228832954
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1309.Fresh fruit intake,50544,-0.105527121172929,0.0237784906886966,-0.152132962922775,-0.058921279423084,9.12731788638906e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1319.Dried fruit intake,49573,-0.101666171169263,0.0256453379677598,-0.151931033586073,-0.0514013087524543,7.38513342865059e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X134.Number of self-reported cancers,51749,0.0926117404626017,0.0453394135073631,0.00374648998816998,0.181476990937033,0.0411001783114756
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51750,0.0114947456151948,0.0224951509956519,-0.0325957503362829,0.0555852415666726,0.609364538152733
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X136.Number of operations, self-reported",51750,0.0332349711100589,0.0214936408621413,-0.00889256497973817,0.0753625071998559,0.122053054504026
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X137.Number of treatments or medications taken,51750,0.0457396095352256,0.0219639417022053,0.00269028379890318,0.0887889352715481,0.0373090176389284
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1438.Bread intake,51210,0.00831330938156941,0.00389461082181076,0.000679872170820314,0.0159467465923185,0.0328070833184441
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1458.Cereal intake,50570,-0.0406706308674063,0.0223765602692065,-0.0845286889950509,0.00318742726023839,0.0691457775718609
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1488.Tea intake,50889,0.0115967550248622,0.00381997261036551,0.00410960870854579,0.0190839013411786,0.0024015815323291
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1498.Coffee intake,49958,-0.00285873881552334,0.0224272963934677,-0.0468162397467199,0.0410987621156733,0.898572038830875
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X1528.Water intake,49641,-0.105987535058795,0.022600054020671,-0.15028364093931,-0.0616914291782799,2.75319583561132e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1568.Average weekly red wine intake,46230,-0.157752728668749,0.0251523200890015,-0.207051276043192,-0.108454181294306,3.64982110642658e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46222,-0.136466343572838,0.0264416854849757,-0.18829204712339,-0.0846406400222857,2.4826108304774e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1588.Average weekly beer plus cider intake,46293,0.0465592185406233,0.0263082865406607,-0.00500502307907178,0.0981234601603183,0.0767852043352443
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1598.Average weekly spirits intake,46219,-0.0470225419857895,0.0270279888971831,-0.0999974002242683,0.00595231625268925,0.0819164997589017
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1608.Average weekly fortified wine intake,46261,-0.0440588778034068,0.0486696712758413,-0.139451433504056,0.051333677897242,0.36533814887562
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X1737.Childhood sunburn occasions,45638,-0.0800199540802828,0.0263864504072387,-0.131737396878471,-0.0283025112820949,0.00242809095447869
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1807.Father's age at death,45831,-0.0085242366815105,0.00447328493241267,-0.0172918751490393,0.000243401786018328,0.0567203469936696
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1845.Mother's age,37113,-0.0247204602627651,0.00973921203498298,-0.0438093158513318,-0.0056316046741985,0.0111588143820678
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1873.Number of full brothers,51351,-0.0125758329113875,0.0216022356283665,-0.0549162147429857,0.0297645489202108,0.560468566708927
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X1883.Number of full sisters,51353,0.0367685918420803,0.0215583852119473,-0.00548584317333641,0.079023026857497,0.0881082421952804
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20015.Sitting height,51545,-0.00585062300354301,0.00503577665651983,-0.0157207452503219,0.00401949924323586,0.245324145118811
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20016.Fluid intelligence score,35991,-0.066862303730094,0.0360564369120053,-0.137532920077624,0.00380831261743639,0.063724809439705
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20018.Prospective memory result,36331,0.101835135961227,0.046978638788639,0.00975700393549453,0.193913267986959,0.0302126861891008
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35908,-0.00609987426112341,0.0067497933822436,-0.0193294692903209,0.00712972076807405,0.366177530456617
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35912,0.000664584746484373,0.00679211679665303,-0.0126479641749556,0.0139771336679243,0.922056877558175
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20023.Mean time to correctly identify matches,51443,0.00715876044480884,0.00396119436003092,-0.000605180500851754,0.0149227013904694,0.070740710653934
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48373,-0.0135567903195963,0.0087055578233639,-0.0306196836533895,0.00350610301419694,0.11942549921997
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,47929,-0.0199892763348678,0.0195971217990448,-0.0583996350609956,0.01842108239126,0.30773609410969
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47891,0.0281751946152762,0.025786652221494,-0.022366643738852,0.0787170329694044,0.274571210786625
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#12.Illnesses of father_Severe depression,47914,0.0404095816444907,0.023216909238649,-0.00509556046326125,0.0859147237522427,0.0817830213951832
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,47934,-0.0238465188942978,0.0154379048195723,-0.0541048123406596,0.00641177455206399,0.122441680715634
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#2.Illnesses of father_Stroke,48106,0.000143704141057783,0.0111026933840883,-0.0216175748917552,0.0219049831738708,0.989673258502726
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48056,0.0115979380164951,0.0141177330860874,-0.0160728188322362,0.0392686948652264,0.411362706333421
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,47950,0.0185276718369005,0.017176641993611,-0.0151385464705772,0.0521938901443781,0.280754971072961
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48076,0.0159668259340485,0.0131723424269517,-0.00985096522277678,0.0417846170908738,0.225470512325843
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48164,-0.0144396757342664,0.00986773213248327,-0.0337804307139336,0.0049010792454008,0.143395183654492
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20107#9.Illnesses of father_Diabetes,48025,-0.00877738125178776,0.0135538857310372,-0.0353429972846206,0.0177882347810451,0.517256846776754
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49130,0.009205129043116,0.0104728078061611,-0.0113215742569597,0.0297318323431917,0.379435845770677
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,48972,0.0013911544895978,0.0146887545623921,-0.0273988044526908,0.0301811134318863,0.924547050198212
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,48895,0.00310967145640794,0.03241695018681,-0.0604275509097397,0.0666468938225556,0.923579236133546
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,48928,0.0115305402541255,0.0174342337716683,-0.0226405579383443,0.0457016384465952,0.508380310445453
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49071,0.0148710634527161,0.0117313290603478,-0.00812234150556564,0.0378644684109979,0.20494213210213
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,48969,0.0277862837217158,0.0195947276736587,-0.0106193825186553,0.0661919499620869,0.156191761318221
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,48934,-0.00926560604757033,0.0178399688737744,-0.0442319450401681,0.0257007329450275,0.603506000392407
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,48945,-0.0146824796854369,0.0148915082333685,-0.0438698358228392,0.0145048764519653,0.324162877736529
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,48981,0.0557110463529882,0.0178767351939534,0.0206726453728396,0.0907494473331368,0.00183328494077457
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49180,0.0147940894694653,0.0089966551663675,-0.00283935465661501,0.0324275335955456,0.100109114686807
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49031,0.0157181713344904,0.0135176580638999,-0.0107764384707534,0.0422127811397342,0.244929085716007
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46155,0.0202736334449112,0.0143681299601072,-0.00788790127689897,0.0484351681667213,0.158258188002937
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46011,0.00697279406669092,0.0585502101509935,-0.107785617829256,0.121731205962638,0.905204756820099
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46003,-0.0797876433372099,0.0570356220339743,-0.1915774625238,0.0320021758493798,0.161858103239672
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46059,-0.000177431924837203,0.0187290767958709,-0.0368864224447442,0.0365315585950697,0.992441376043296
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46021,0.0495787328455517,0.0335284435153428,-0.0161370164445202,0.115294482135624,0.139236810631808
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46053,-0.0222868374892208,0.0238375175050891,-0.0690083717991954,0.0244346968207538,0.349828073211022
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46025,0.0476365874001166,0.0275005444923782,-0.0062644798049447,0.101537654605178,0.0832547212452334
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46029,-0.0202048256152952,0.0269657277128667,-0.0730576519325139,0.0326480007019234,0.45369979774963
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46035,-0.000850371232793169,0.0210938944744781,-0.0421944044027703,0.040493661937184,0.967843557515025
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46053,0.0202309597886633,0.0268930757989553,-0.032479468777289,0.0729413883546157,0.45189648818382
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46219,-0.0197324488270762,0.0109070108152557,-0.0411101900249773,0.0016452923708249,0.0704443094163215
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46119,-0.0217669364713043,0.0151911212570781,-0.0515415341351773,0.00800766119256873,0.151912185667255
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20127.Neuroticism score,47254,0.0246958100397904,0.0224400349225732,-0.0192866584084531,0.0686782784880339,0.271117834912332
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35991,-0.0478738211186094,0.0365893154951277,-0.11958887948906,0.0238412372518408,0.190775076930076
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X20161.Pack years of smoking,36678,0.0860323589104407,0.00723005885217322,0.0718614435601811,0.1002032742607,2.22391780169326e-32
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36678,0.0883073107056581,0.00712510894773754,0.0743420971680925,0.102272524243224,5.8602598593031e-35
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20191.Fluid intelligence score,34127,-0.0154119519331981,0.0444019741955893,-0.102439821356553,0.0716159174901569,0.728528985992259
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34128,-0.013488149541089,0.0450439446308208,-0.101774281017498,0.0747979819353197,0.764612396892553
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X20240.Maximum digits remembered correctly,33605,0.00855032756811627,0.0472522171202389,-0.0840640179875519,0.101164673123784,0.856413514815886
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X20255.Spirometry QC measure,45127,0.00755567622195978,0.0276888916688925,-0.0467145514490694,0.061825903892989,0.784950772679715
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X20261.avMSE,33692,-0.00367851972540304,0.00844483286854194,-0.0202303921477452,0.0128733526969392,0.663149685364449
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X20262.Myopia diagnosis,33692,0.00664045686240327,0.0549459621430224,-0.101053628937921,0.114334542662727,0.903811193951085
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X20280.Glucose-lactate,41816,-0.00120801039973306,0.00491725472445003,-0.0108458296596551,0.008429808860189,0.805943333199288
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X20281.Spectrometer-corrected alanine,41840,0.010622330112809,0.00520949850932394,0.000411713034534059,0.0208329471910839,0.0414667297777511
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35751,0.00472873073948538,0.0323403562053761,-0.0586583674230517,0.0681158289020225,0.883753697609215
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35751,-0.0137183573384249,0.0713359437890461,-0.153536807164955,0.126100092488105,0.847507679283191
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35751,0.0876199082205149,0.0855659687989997,-0.0800893906255244,0.255329207066554,0.305867947106092
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35751,0.000686205651077258,0.03133549397455,-0.0607313625390407,0.0621037738411952,0.982529396453422
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35751,-0.0430473948522013,0.0443688954292139,-0.130010429893461,0.043915640189058,0.331971846415452
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35755,0.00251503114109594,0.0597397887426095,-0.114574954794419,0.119605017076611,0.966420341222497
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35755,-0.0271732984711476,0.0379864515072783,-0.101626743425413,0.0472801464831179,0.474421176434014
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35755,0.0232371025272031,0.0431944451969531,-0.061424010058825,0.107898215113231,0.590617899589799
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35755,0.178342909019873,0.0624752912446859,0.0558913381802883,0.300794479859457,0.00432128950829123
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35755,0.0657366424675534,0.0697799290420918,-0.0710320184549466,0.202505303390053,0.34619546986891
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35755,0.0513697293401326,0.0455752943314512,-0.0379578475495117,0.140697306229777,0.259721165093019
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35755,0.0356345274771663,0.067400160470239,-0.0964697870445022,0.167738841998835,0.597029331573167
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35755,0.0411936225526079,0.0550710299624416,-0.0667455961737776,0.149132841278993,0.454479351570101
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35757,0.02546274170627,0.0929896238860643,-0.156796921110416,0.207722404522956,0.78422818631747
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35757,0.0290136499592843,0.041163520477103,-0.0516668501758376,0.109694150094406,0.480933441091449
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35757,0.0227250072591783,0.0544232596208971,-0.0839445815977801,0.129394596116137,0.676280956869019
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35757,0.0633753024677651,0.11468848624893,-0.161414130580138,0.288164735515668,0.580563885311169
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20600.Liking for adding salt to foods,36437,0.00931081179847762,0.0372079568074818,-0.0636167835441867,0.082238407141142,0.802410550584349
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20601.Liking for aniseed,36437,0.0242200496304711,0.03677277104023,-0.0478545816083797,0.096294680869322,0.510145787803973
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20602.Liking for apple juice,36437,-0.0204871522614217,0.0369206287157774,-0.0928515845443455,0.051877280021502,0.578980854444611
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20603.Liking for apples,36437,-0.0910788385459086,0.0376807621159126,-0.164933132293097,-0.0172245447987199,0.0156666638137365
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20604.Liking for asparagus,36437,-0.156157826582078,0.0373806388945597,-0.229423878815415,-0.0828917743487408,2.97924879425221e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20605.Liking for aubergine,36437,-0.170971321362683,0.0371353627018358,-0.243756632258281,-0.0981860104670845,4.20984648831158e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20606.Liking for avocados,36437,-0.127543760560351,0.0370552836946795,-0.200172116601923,-0.0549154045187793,0.000580480200144881
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20607.Liking for bacon,36437,0.0105920762656303,0.0379713641531453,-0.0638317974745345,0.0850159500057952,0.780291287967998
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20608.Liking for baked or steamed fish,36437,0.0116305231892248,0.0376537802296638,-0.0621708860609163,0.085431932439366,0.757420555246869
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20609.Liking for bananas,36437,-0.0562800275979207,0.0383525665093727,-0.131451057956291,0.0188910027604498,0.142297018427087
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36437,-0.105664516401081,0.0377928890698276,-0.179738578977943,-0.0315904538242192,0.005188419804459
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20611.Liking for beef steak,36437,-0.097751514061658,0.0378168197916596,-0.171872480853311,-0.0236305472700052,0.00975953112287916
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20612.Liking for beetroot,36437,0.0352968133599065,0.0369420918542525,-0.0371096866744284,0.107703313394241,0.33937295563202
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20613.Liking for bell pepper,36437,-0.0706654372629333,0.0371529280870193,-0.143485176313491,0.00215430178762452,0.0572058261256136
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20614.Liking for bicycling,36437,-0.103803896384399,0.0369508164739735,-0.176227496673387,-0.0313802960954114,0.00497809739686479
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20615.Liking for biscuits,36437,-0.0171217390282396,0.0373383341748597,-0.0903048740109646,0.0560613959544853,0.64656534931562
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20616.Liking for bitter foods,36437,-0.0278828017391785,0.0369432220942231,-0.100291517043856,0.0445259135654987,0.450423250236931
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20617.Liking for bitter or ale,36437,-0.0204830185445363,0.0369582461285452,-0.0929211809564849,0.0519551438674123,0.579443765574016
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20618.Liking for black olives,36437,-0.0480855785495474,0.0370309448620346,-0.120666230479135,0.0244950733800404,0.19414551318295
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20619.Liking for black pepper,36437,-0.0474620439804132,0.0375220274669482,-0.121005217815632,0.0260811298548053,0.205940709177468
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20620.Liking for blue cheese,36437,-0.0493042180578702,0.0372320238531994,-0.122278984810141,0.0236705486944006,0.185461274689977
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20621.Liking for bolognese sauce,36437,-0.0481872951962647,0.0372488505931672,-0.121195042358872,0.0248204519663429,0.195821547514144
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20622.Liking for broad beans,36437,-0.0460690591733088,0.0370699470514082,-0.118726155394069,0.0265880370474514,0.213993393403504
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20623.Liking for broccoli,36437,-0.0643393652183192,0.0376417700521419,-0.138117234520517,0.00943850408387883,0.0874434513130566
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20624.Liking for brown rice,36437,-0.106472564472029,0.0372932793466728,-0.179567391991508,-0.0333777369525502,0.00431490515649108
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20625.Liking for brussel sprouts,36437,-0.0358997503001205,0.0374575144656991,-0.109316478652891,0.0375169780526497,0.337884390840341
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20626.Liking for burgers (meat),36437,0.00199164654959458,0.0370033560491603,-0.0705349313067595,0.0745182244059487,0.957077237020385
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20627.Liking for burn of spicy foods,36437,-0.0153103127012919,0.0368575373685089,-0.0875510859435695,0.0569304605409856,0.677866614668696
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20628.Liking for butter on bread,36437,0.0687625402322002,0.0374531332057304,-0.00464560085103131,0.142170681315432,0.0664011398809846
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20629.Liking for butternut squash,36437,-0.110326474958752,0.0369509614274477,-0.18275035935655,-0.0379025905609548,0.00283755458957155
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20630.Liking for cabbage,36437,-0.0485707486861995,0.0373525663415809,-0.121781778715698,0.0246402813432992,0.19352538248644
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20631.Liking for cake,36437,-0.0189772090701718,0.0368845792631801,-0.0912709844260047,0.0533165662856611,0.606915222343266
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20632.Liking for cake icing,36437,0.0206727282666438,0.0368367336344808,-0.0515272696569385,0.0928727261902261,0.574678130204509
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20633.Liking for capers,36437,-0.0726580080179348,0.0369140997185486,-0.14500964346629,-0.00030637256957948,0.049068809962514
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20634.Liking for cauliflower,36437,-0.0678532146705511,0.037566959328969,-0.14148445495533,0.00577802561422806,0.0709264414741707
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20635.Liking for cereal or granola bar,36437,-0.0670148252964294,0.0370012360376522,-0.139537247930228,0.00550759733736894,0.0701557964605864
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20636.Liking for cheesecake,36437,-0.027086775924958,0.0372688509295448,-0.100133723746866,0.0459601718969498,0.467373913595985
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20637.Liking for cherries,36437,-0.0293552338176629,0.0378089315686601,-0.103460739692237,0.0447502720569109,0.437530380509548
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20638.Liking for chicken,36437,-0.0176862528089256,0.0386046183051463,-0.0933513046870123,0.0579787990691612,0.646865827175348
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20639.Liking for chilli pepper,36437,0.00330442009818966,0.0370558856365429,-0.0693251157494343,0.0759339559458137,0.928945940333397
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20640.Liking for chips or french fries,36437,0.0298050399563128,0.0375834175230833,-0.0438584583889305,0.103468538301556,0.427780312201541
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20641.Liking for cigarette smoking,36437,0.197971740730905,0.0566172452555679,0.0870019400299916,0.308941541431818,0.000473719583202044
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20642.Liking for cod,36437,-0.0441972976880132,0.0384459753856091,-0.119551409443807,0.0311568140677806,0.250345875696199
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20643.Liking for coffee with sugar,36437,0.0841335642723839,0.0384668176488467,0.00873860168064435,0.159528526864123,0.0287594215624282
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20644.Liking for coffee without sugar,36437,-0.0864816853058397,0.0375544902962281,-0.160088486286447,-0.0128748843252327,0.0213143888893013
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20645.Liking for coriander,36437,-0.0762885499319616,0.0374674630853491,-0.149724777579246,-0.0028523222846774,0.0417711001920159
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20646.Liking for corn flakes,36437,0.0463862209022088,0.0371641209035599,-0.0264554560687685,0.119227897873186,0.212015201593594
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20647.Liking for cream,36437,0.042166887641897,0.0371530693100122,-0.030653128205727,0.114986903489521,0.256430887720689
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20648.Liking for croissant,36437,-0.0277605540230961,0.0369408963080242,-0.100164710786823,0.0446436027406313,0.452383016480774
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20649.Liking for cucumber,36437,-0.0731415712884649,0.0372083497177817,-0.146069936735317,-0.000213205841612663,0.0493650951814948
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20650.Liking for curry,36437,-0.0379516301394665,0.0377915479272371,-0.112023064076851,0.0361198037979183,0.315295949819459
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20651.Liking for dairy products,36437,-0.0261728256540985,0.037822204011511,-0.10030434551666,0.0479586942084629,0.48896016980612
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20652.Liking for dark chocolate,36437,0.00730283613285901,0.0376145809051062,-0.0664217424411491,0.0810274147068672,0.846064193221858
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20653.Liking for diet fizzy drinks,36437,-0.0244211302365243,0.0372689890428213,-0.097468348760454,0.0486260882874055,0.512315263918778
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20654.Liking for dried fruit,36437,-0.057643611457456,0.0375738514934747,-0.131288360384666,0.0160011374697544,0.125035215497041
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20655.Liking for eggs,36437,0.0443314928141693,0.0384201863788383,-0.0309720724883537,0.119635058116692,0.24859304770533
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20656.Liking for exercising alone,36437,-0.0960058573961706,0.0370658268737342,-0.16865487806869,-0.0233568367236516,0.00961133664753845
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20657.Liking for exercising with others,36437,-0.0604915465330832,0.036944875115243,-0.132903501758959,0.011920408692793,0.101598371882751
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20658.Liking for extra virgin olive oil,36437,-0.0353690609710163,0.0376336973507857,-0.109131107778556,0.0383929858365237,0.347336721962413
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20659.Liking for fatty foods,36437,0.0300119945597098,0.0370468494549711,-0.0425998303720336,0.102623819491453,0.417902027380635
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20660.Liking for fresh tomatoes,36437,-0.0602966529385847,0.0385044079480821,-0.135765292516826,0.0151719866396563,0.117396637732569
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20661.Liking for fried chicken,36437,-0.0013022450178802,0.0368386944910395,-0.0735060862203177,0.0709015961845573,0.971801616621025
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20662.Liking for fried or battered fish,36437,0.0430339332124699,0.0374350780254196,-0.0303388197173525,0.116406686142292,0.25035954652239
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20663.Liking for fruit,36437,-0.0425506084855318,0.0393722114208462,-0.11972014287039,0.0346189258993267,0.279851901764539
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20664.Liking for garlic,36437,-0.0921030227323978,0.0376359867768892,-0.165869556815101,-0.018336488649695,0.0144186676958837
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20665.Liking for gherkins,36437,0.00795963931839445,0.0368253602731249,-0.0642180668169302,0.0801373454537192,0.828879893715326
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20666.Liking for globe artichoke,36437,-0.0951085596972222,0.0369541462512689,-0.167538686349709,-0.0226784330447351,0.010080233459286
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20667.Liking for goat's cheese,36437,-0.0750925262883199,0.0369390742685817,-0.14749311185474,-0.00269194072189978,0.0420988144117119
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20668.Liking for going to a cafe,36437,0.0137071770977076,0.0369269984278582,-0.0586697398208944,0.0860840940163096,0.710501133893956
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20669.Liking for going to the gym,36437,-0.105936058742478,0.0369091857242575,-0.178278062762022,-0.0335940547229329,0.00411335768607245
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20670.Liking for going to the pub,36437,-0.0225231525814729,0.0368735767286915,-0.0947953629697081,0.0497490578067624,0.541335867383012
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20671.Liking for grapefruit,36437,-0.0705591761459868,0.0367772008872913,-0.142642489885078,0.00152413759310412,0.0550766825395088
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20672.Liking for green olives,36437,-0.0389863849130955,0.0371635343655728,-0.111826912269618,0.0338541424434273,0.294187750837421
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20673.Liking for haddock,36437,-0.038890642518096,0.038097384285865,-0.113561515718391,0.0357802306821994,0.307370394338841
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20674.Liking for ham,36437,-0.0101100982177487,0.0374240394577686,-0.0834612155549752,0.0632410191194779,0.787052102830947
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20675.Liking for hard cheese,36437,-0.00134828008237727,0.0378117524893435,-0.0754593149614905,0.0727627547967359,0.971556209713904
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20676.Liking for herring,36437,0.00484226682741913,0.0369622569117498,-0.0676037567196106,0.0772882903744488,0.89577415437589
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20677.Liking for honey,36437,-0.0339242630781746,0.0370568443117534,-0.106555677929211,0.038707151772862,0.359975497157644
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20678.Liking for horseradish or wasabi,36437,-0.0273531248826751,0.036940172461828,-0.0997558629078579,0.0450496131425077,0.459036485564323
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20679.Liking for ice cream,36437,-0.0326707184827234,0.0377277891130482,-0.106617185144298,0.0412757481788511,0.386539186106022
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20680.Liking for jam,36437,0.042354982404557,0.0374284510684257,-0.0310047816895573,0.115714746498671,0.257826660945837
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20681.Liking for kiwi fruit,36437,-0.0145050467275559,0.0370590107474128,-0.0871407077924849,0.0581306143373732,0.695509255808869
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20682.Liking for lager,36437,-0.0614029398049743,0.0370520089097032,-0.134024877267993,0.011218997658044,0.0975172066436158
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20683.Liking for lamb,36437,-0.0913072074004772,0.0377346171064688,-0.165267056929156,-0.0173473578717983,0.0155550935715679
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20684.Liking for lemons,36437,-0.0727802761036872,0.037382708742386,-0.146050385238764,0.000489833031389331,0.051582826183231
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20685.Liking for lentils or beans,36437,0.012598699225743,0.0370897045170537,-0.0600971216276822,0.0852945200791681,0.734105248992701
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20686.Liking for liver,36437,0.04853861779204,0.0371053441366248,-0.0241878567157446,0.121265092299825,0.190867593366886
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20687.Liking for mackerel,36437,-0.0535022670985981,0.0373723240884689,-0.126752022311997,0.0197474881148008,0.152297885567503
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20688.Liking for marzipan,36437,0.00678382683381678,0.0370302569857458,-0.065795476858245,0.0793631305258786,0.854648301898221
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20689.Liking for mayonnaise,36437,-0.0700606561040288,0.036898686460391,-0.142382081566395,0.00226076935833763,0.0576366746786786
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20690.Liking for melon,36437,-0.0535772404806651,0.037493343578795,-0.127064193895103,0.0199097129337731,0.153049865136135
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20691.Liking for milk chocolate,36437,0.0284422224995587,0.0374802053317229,-0.0450189799506182,0.101903424949736,0.447959254922129
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20692.Liking for mushrooms,36437,-0.0334852046333083,0.0380226686938053,-0.108009635273167,0.0410392260065501,0.378526613871688
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20694.Liking for orange juice,36437,-0.00474934896291583,0.0372974419271699,-0.0778523351401689,0.0683536372143372,0.898676849977519
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20695.Liking for oranges,36437,-0.0954275528650906,0.0376430900025306,-0.169208009270051,-0.0216470964601307,0.0112620585936025
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20696.Liking for pasta,36437,-0.0639541136551389,0.0376587418031157,-0.137765247589246,0.00985702027896791,0.0894995507641112
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20697.Liking for pears,36437,0.0079086363598236,0.037447509443101,-0.0654884821486543,0.0813057548683015,0.832742493290845
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20698.Liking for pizza,36437,-0.01846272906136,0.0370489414330377,-0.0910786542701139,0.0541531961473938,0.618262992548489
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20699.Liking for plain yogurt,36437,-0.0999352918295597,0.0374869299268611,-0.173409674486207,-0.0264609091729121,0.00769470374669388
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20700.Liking for plums,36437,-0.058108900104548,0.037835610914457,-0.132266697496884,0.0160488972877876,0.124621572484066
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20701.Liking for pollock,36437,0.000309193418032872,0.0371016183782516,-0.0724099786033403,0.0730283654394061,0.993350966053523
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20702.Liking for pork chop,36437,-0.0802779267512799,0.0372793060386609,-0.153345366587055,-0.00721048691550451,0.0313162911226991
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20703.Liking for porridge,36437,-0.0140873088276677,0.037151204701351,-0.0869036700423157,0.0587290523869803,0.704558190692322
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20704.Liking for potato crisps,36437,-0.0148464714650866,0.0374511421396516,-0.0882507100588037,0.0585577671286305,0.691804253119183
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20705.Liking for potatoes,36437,0.0109531338581464,0.0379061841466777,-0.0633429870693419,0.0852492547856348,0.772624425174014
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20706.Liking for prawns,36437,-0.013864534528122,0.0374898484102941,-0.0873446374122984,0.0596155683560545,0.711525845576855
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20707.Liking for raw carrots,36437,-0.0267054188852779,0.0372635402768086,-0.0997419578278228,0.046331120057267,0.473603138371476
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20708.Liking for red meat,36437,-0.0310920144873156,0.0377880238814569,-0.105156541294971,0.0429725123203398,0.410646371853741
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20709.Liking for red wine,36437,-0.101195598631373,0.0378499604954214,-0.175381521202399,-0.0270096760603466,0.00751979634564208
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36437,0.0926104937797654,0.0370115677590794,0.0200678209719699,0.165153166587561,0.0123625134644084
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20711.Liking for roast chicken,36437,-0.0513820582699451,0.0384497082785146,-0.126743486495834,0.0239793699559435,0.181475521961559
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20712.Liking for salad dressing,36437,-0.0678806560395933,0.0369765271588544,-0.140354649270948,0.00459333719176132,0.0664285617707102
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20713.Liking for salad leaves,36437,-0.0664679589435947,0.0374463058310628,-0.139862718372478,0.00692680048528828,0.0759333592649173
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20714.Liking for salami,36437,-0.0625450928557761,0.0370504473547639,-0.135163969671113,0.0100737839595611,0.0914306626529192
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20715.Liking for salmon,36437,-0.0507156451127851,0.0381013996506643,-0.125394388428087,0.023963098202517,0.18320461386873
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20716.Liking for salty foods,36437,-0.0556685345503993,0.0369966872924229,-0.128182041643548,0.0168449725427496,0.132444215380792
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20717.Liking for salty pretzels,36437,-0.071597201509225,0.0370150882806081,-0.144146774539217,0.000952371520766854,0.0531158456087105
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20718.Liking for sardines,36437,0.00511842480093579,0.0369549597405238,-0.0673132962904908,0.0775501458923624,0.889845349198888
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20719.Liking for sausages (meat),36437,0.0278159654678604,0.0377175937176977,-0.0461105182188272,0.101742449154548,0.460852695157825
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20720.Liking for savoury biscuits,36437,-0.0848233992768533,0.0372001522826157,-0.15773569775078,-0.0119111008029264,0.0226232152550002
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36437,-0.0203745849734369,0.0372508456324765,-0.0933862424130908,0.052637072466217,0.584424341073123
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20722.Liking for skimmed milk,36437,-0.0196702809584042,0.0368829723690188,-0.0919609068016809,0.0526203448848726,0.593829963431327
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20723.Liking for smoked fish,36437,0.000122738716738561,0.0374771410941571,-0.0733324578278093,0.0735779352612864,0.997386993201455
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20724.Liking for soft cheese,36437,-0.0177815687949658,0.0370858840660934,-0.0904699015645088,0.0549067639745773,0.631617700738327
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20725.Liking for soy sauce,36437,-0.027647396899284,0.0371897985450346,-0.100539402047552,0.0452446082489838,0.457253707151373
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20726.Liking for soya milk,36437,-0.0673056691911397,0.0372318013113175,-0.140279999761322,0.00566866137904262,0.0706842868486369
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20727.Liking for spicy foods,36437,-0.00576630609211868,0.0372896158903594,-0.0788539532372231,0.0673213410529858,0.877112505578475
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20728.Liking for spinach,36437,-0.119412371284975,0.0372644128856911,-0.19245062054093,-0.0463741220290206,0.00135858156893093
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20729.Liking for spirits,36437,-0.0631287664589109,0.0369406763068092,-0.135532492020257,0.00927495910243517,0.0875048770766143
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20730.Liking for strawberries,36437,-0.039814989755516,0.0387225109163959,-0.115711111151652,0.0360811316406201,0.303881406072682
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36437,0.0553936307021636,0.0373261495066641,-0.017765622330898,0.128552883735225,0.137837634626054
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20732.Liking for sweet foods,36437,0.0187708480225403,0.0369389586661903,-0.0536295109631927,0.0911712070082734,0.61135646914885
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20733.Liking for taking the stairs,36437,-0.0946425484428939,0.0381254164100757,-0.169368364606642,-0.0199167322791454,0.0130708593464549
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20734.Liking for tea with sugar,36437,0.101249342220975,0.0404304408749446,0.0220056781060841,0.180493006335867,0.0122900954951941
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20735.Liking for tea without sugar,36437,-0.109734012202933,0.0382191030688498,-0.184643454217879,-0.0348245701879871,0.00410036931836524
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20736.Liking for tomato ketchup,36437,0.0300141075807057,0.0369661449155634,-0.0424395364537986,0.10246775161521,0.416853607444461
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20737.Liking for tinned tuna,36437,-0.06174642979709,0.0370128788008333,-0.134291672246723,0.0107988126525433,0.0953077397384376
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20738.Liking for turnip (white),36437,-0.0214973855324117,0.0371269860239483,-0.0942662781393504,0.051271507074527,0.562590192436923
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20739.Liking for vegetables,36437,-0.0871923826177037,0.0387689794411742,-0.163179582322405,-0.0112051829130023,0.0245386275558439
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20740.Liking for vinegar,36437,-0.00736071459485833,0.0369773143137116,-0.0798362506497331,0.0651148214600165,0.842220760084308
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20741.Liking for watching television,36437,0.026777559635338,0.0372917648606007,-0.0463142994914395,0.0998694187621154,0.47274444991764
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20742.Liking for whisky,36437,-0.0223384650994538,0.0369055516533444,-0.0946733463400089,0.0499964161411013,0.545005604084459
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20743.Liking for white bread,36437,0.0599440826150932,0.0369638565045958,-0.0125050761339146,0.132393241364101,0.104909050861061
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20744.Liking for white rice,36437,-0.0110854082247708,0.0371417776274188,-0.0838832923745117,0.0617124759249701,0.765358517365678
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20745.Liking for white wine,36437,-0.100442816947135,0.0369757989509548,-0.172915382891007,-0.0279702510032638,0.00661316336550359
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36437,-0.126955186039871,0.0374307499187949,-0.200319455880709,-0.0535909161990325,0.000697953811824361
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20747.Liking for whole milk,36437,0.0289695763472207,0.0366828358345796,-0.0429287818885553,0.100867934582997,0.429708744111054
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20748.Liking for wholemeal bread,36437,-0.0819148230886428,0.0384286135776663,-0.157234905700869,-0.00659474047641675,0.0330699622872807
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X20749.Liking for working up a sweat,36437,-0.0968049351635279,0.0374904058612704,-0.170286130651618,-0.023323739675438,0.00983738293027119
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21001.Body mass index (BMI),51613,0.0347501845257719,0.0201098898983151,-0.0046651996749256,0.0741655687264694,0.0839990112253463
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21002.Weight,51645,-0.027649118002199,0.00973313086163647,-0.0467260544910065,-0.00857218151339148,0.00450510009641409
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X21021.Pulse wave Arterial Stiffness index,36322,-0.000165798377358096,0.00726459558028189,-0.0144044057147106,0.0140728089599944,0.981792214486814
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36201,-0.0688425704702575,0.0410652475984977,-0.149330455763313,0.011645314822798,0.0936972568047093
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36203,0.0866977782234025,0.0416037563721521,0.00515441573398434,0.168241140712821,0.0372032212374679
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36204,0.0904748282693561,0.0402924072010628,0.0115017101552731,0.169447946383439,0.0247674945057425
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21040.Satisfaction with bowel habits,36177,-0.0279375613878159,0.0373702774620644,-0.101183305213462,0.0453081824378303,0.454732087612142
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36175,-0.0287762554058094,0.0410799836083648,-0.109293023278204,0.0517405124665857,0.483640795463683
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21042.Greatest number of times bowels opened per day,36172,-0.0499726634328193,0.0402024652608532,-0.128769495344092,0.0288241684784529,0.213897168608968
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21043.Least number of times bowels opened per week,36139,-0.0425666585473509,0.0402266027762972,-0.121410799988893,0.0362774828941916,0.290011011734596
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21044.Average number of times bowels opened per day,36148,0.07439754217836,0.0440169693631847,-0.011875717773482,0.160670802130202,0.091030771150938
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36210,0.0182894960257235,0.0404893810817896,-0.0610696908945841,0.097648682946031,0.651490117189529
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36206,0.0546254139003316,0.0408134224382119,-0.0253688940785637,0.134619721879227,0.180800268508323
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36208,-0.0316010710687735,0.0468990255751904,-0.123523161196147,0.0603210190585996,0.50045206515475
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36208,-0.00796612939914055,0.0589381839831483,-0.123484970006111,0.10755271120783,0.89248835196073
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36208,-0.0157983429399059,0.0494218725761612,-0.112665213189182,0.08106852730937,0.749232606400589
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36207,0.0211002215615989,0.118058788587311,-0.21029500406953,0.252495447192728,0.858157303659574
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36210,-0.00169437529675094,0.0500947145913129,-0.0998800158957243,0.0964912653022224,0.973018835801333
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36208,-0.164448057506088,0.0456315393550369,-0.25388587464196,-0.0750102403702154,0.000315572733539975
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36068,0.0816528915417153,0.0459335897507749,-0.00837694436980348,0.171682727453234,0.0755054663749523
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36204,0.0611222266473538,0.0413795945570548,-0.0199817786844736,0.142226231979181,0.139687482803095
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36209,-0.0812188584570518,0.0698713664102754,-0.218166736621192,0.0557290197070879,0.245107264082074
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36210,-0.102801494629354,0.0408132900416632,-0.182795543111014,-0.0228074461476942,0.0117950811229519
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36209,-0.00841352144291044,0.0405128727011905,-0.0878187519372439,0.070991709051423,0.835488093324387
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X21100.Water hardness (USGS classification),51485,-0.0516339878639827,0.0216573157135291,-0.0940823266624998,-0.00918564906546556,0.017127370618657
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2139.Age first had sexual intercourse,48720,-0.0221290043566229,0.00394994640071331,-0.029870899302021,-0.0143871094112249,2.14224465518019e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2149.Lifetime number of sexual partners,47071,0.0666021911488697,0.0252357807215436,0.0171400609346443,0.116064321363095,0.0083172497104492
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22032.IPAQ activity group,47933,-0.0372709098222331,0.0237351304877342,-0.0837917655781921,0.00924994593372596,0.116365281814776
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22033.Summed days activity,48329,-0.00857127675272229,0.00393581114562356,-0.0162854665981445,-0.000857086907300111,0.0294352473444741
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22034.Summed minutes activity,47933,-0.00782477388359841,0.00397709101697365,-0.0156198722768668,-2.96754903300455e-05,0.049144292040254
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22037.MET minutes per week for walking,47228,0.00165944712807462,0.00406741006054548,-0.00631267659059453,0.00963157084674377,0.683288503737969
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22038.MET minutes per week for moderate activity,47933,-0.00645951457416729,0.00404384874964429,-0.0143854581234701,0.00146642897513553,0.110200045138761
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22039.MET minutes per week for vigorous activity,47933,-0.0685211683321139,0.0237214787857685,-0.11501526675222,-0.0220270699120077,0.0038742665972702
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X22040.Summed MET minutes per week for all activity,47228,-0.00576856976706201,0.00403599570569427,-0.0136791213502228,0.00214198181609876,0.152940411148495
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X2217.Age started wearing glasses or contact lenses,48007,0.00220491930333843,0.00413590947344774,-0.00590146326461914,0.010311301871296,0.593959424064008
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X22501.Year ended full time education,34050,-0.025305397247032,0.0174294806588076,-0.059467179338295,0.00885638484423092,0.146594405232592
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X22506.Tobacco smoking,34013,-0.219559608165764,0.0846635955904247,-0.385500255522997,-0.0536189608085318,0.00953108916649735
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50289,-0.0523578534269818,0.0682558147359816,-0.186139250309506,0.0814235434555421,0.443040707876149
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23098.Weight,51213,-0.0265375780916508,0.00982013002138376,-0.0457850329335629,-0.00729012324973861,0.00688994643423511
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23099.Body fat percentage,51184,0.0280754075874136,0.00874269021341994,0.0109397347691106,0.0452110804057167,0.00132320570236231
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23100.Whole body fat mass,51143,0.0152927597184772,0.00873542206875613,-0.0018286675362848,0.0324141869732393,0.0800179823463045
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23101.Whole body fat-free mass,51207,-0.035618594779942,0.00847607981578393,-0.0522317112188785,-0.0190054783410055,2.65290634590668e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23102.Whole body water mass,51213,-0.0338140356141562,0.00845376205720596,-0.0503834092462798,-0.0172446619820325,6.35760805245286e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23104.Body mass index (BMI),51213,0.0341919791628171,0.0198926199336776,-0.00479755590719103,0.0731815142328252,0.0856595009426636
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23105.Basal metabolic rate,51213,-0.0356881334607514,0.00880828875726997,-0.0529523794250006,-0.0184238874965023,5.10267622804637e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23106.Impedance of whole body,51213,0.0202569640974565,0.00693285452768601,0.00666856922319195,0.0338453589717211,0.00348270585311019
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23107.Impedance of leg (right),51213,0.0267734450523941,0.00560360354211444,0.0157903821098498,0.0377565079949384,1.78248636860174e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23108.Impedance of leg (left),51213,0.0245265488494009,0.00559287282918831,0.0135645181041918,0.03548857959461,1.16337043233452e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23109.Impedance of arm (right),51213,0.00758590369801175,0.00685950416172604,-0.00585872445897129,0.0210305318549948,0.268782955481955
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23110.Impedance of arm (left),51213,0.00650225466431203,0.00685854967519462,-0.00694050269906942,0.0199450120276935,0.343113638533656
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23111.Leg fat percentage (right),51213,0.0412934142190467,0.00890299527055398,0.0238435434887609,0.0587432849493325,3.53511453096036e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23112.Leg fat mass (right),51213,0.0308306559397442,0.00959498920656815,0.0120244770948706,0.0496368347846178,0.00131447049143349
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23113.Leg fat-free mass (right),51212,-0.0435663291049891,0.009317569853499,-0.0618287660178471,-0.025303892192131,2.94617892024732e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23114.Leg predicted mass (right),51212,-0.0432966169229265,0.00938604072041404,-0.061693256734938,-0.0248999771109149,3.99316710715451e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23115.Leg fat percentage (left),51212,0.038046575694407,0.0093307739862862,0.0197582586812861,0.056334892707528,4.56709946144511e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23116.Leg fat mass (left),51212,0.0275100277027249,0.0101642313378272,0.00758813428058367,0.0474319211248662,0.00680368122638907
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23117.Leg fat-free mass (left),51211,-0.0429399742679314,0.0101477845071083,-0.0628296319018637,-0.0230503166339991,2.33090728948505e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23118.Leg predicted mass (left),51211,-0.043192838792438,0.0102283776641824,-0.0632404590142356,-0.0231452185706404,2.42182104288875e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23119.Arm fat percentage (right),51211,0.0150498790558513,0.00982544100205686,-0.00420798530818016,0.0343077434198827,0.125604163950067
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23120.Arm fat mass (right),51210,0.00174996594408819,0.0107273578194046,-0.0192756553819447,0.0227755872701211,0.870416652162352
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23121.Arm fat-free mass (right),51209,-0.0302024402959856,0.00929130909020428,-0.048413406112786,-0.0119914744791852,0.00115325372615348
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23122.Arm predicted mass (right),51209,-0.030402717325219,0.00933282710079176,-0.0486950584427708,-0.0121103762076671,0.00112520092181418
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23123.Arm fat percentage (left),51207,0.0124855309135227,0.00925955525496189,-0.00566319738620265,0.030634259213248,0.177545126052062
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23124.Arm fat mass (left),51207,-0.00165858014313247,0.0103127807741857,-0.0218716304605365,0.0185544701742716,0.872230595942238
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23125.Arm fat-free mass (left),51203,-0.024332972237297,0.00846549399032334,-0.0409253404583307,-0.00774060401626322,0.00405210399413864
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23126.Arm predicted mass (left),51202,-0.0244999040059396,0.00851153101534241,-0.0411825047960108,-0.00781730321586853,0.00400026027083349
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23127.Trunk fat percentage,51200,0.0189418997960472,0.00740959020179223,0.00441910300053444,0.03346469659156,0.0105825286136351
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23128.Trunk fat mass,51200,0.00687433218381383,0.00781286172981306,-0.00843887680661978,0.0221875411742474,0.37893704583875
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23129.Trunk fat-free mass,51199,-0.0278882686865084,0.00734636759962467,-0.0422871491817728,-0.0134893881912441,0.00014731567332707
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X23130.Trunk predicted mass,51197,-0.0287442489563989,0.00734000521401566,-0.0431306591758696,-0.0143578387369282,9.02544767840031e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23400.Total Cholesterol,41843,0.0149591103227702,0.0052069872864244,0.00475341524137841,0.0251648054041621,0.00407379924337984
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,41843,0.0260804146856332,0.00508428738106984,0.0161152114187363,0.0360456179525301,2.94444645790553e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",41843,0.0330658691456694,0.00511292263619918,0.023044540778719,0.0430871975126198,1.03397960187416e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23403.VLDL Cholesterol,41843,0.0450766158634661,0.00526981362426248,0.0347477811599116,0.0554054505670206,1.32147662127253e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23404.Clinical LDL Cholesterol,41843,0.0185592021688355,0.00507664601514862,0.00860897597914422,0.0285094283585268,0.00025737342597579
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23405.LDL Cholesterol,41843,0.0191660169541229,0.00505123771169524,0.00926559103920018,0.0290664428690455,0.000148707073892134
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23406.HDL Cholesterol,41843,-0.0410225242974837,0.00575882565714511,-0.0523098225854881,-0.0297352260094792,1.1072266790632e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23407.Total Triglycerides,41843,0.0365171878472059,0.00537303932114193,0.0259860307777677,0.047048344916644,1.11876353341684e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23408.Triglycerides in VLDL,41843,0.0347813304730546,0.00545473634476087,0.0240900472373233,0.0454726137087859,1.87374060477498e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23409.Triglycerides in LDL,41843,0.0404351409599651,0.00505410097015364,0.030529103058464,0.0503411788614663,1.34208528320846e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23410.Triglycerides in HDL,41843,0.0272458790346003,0.00526496302248383,0.0169265515105319,0.0375652065586686,2.31315138134433e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,41843,0.011729180731686,0.00523525896808892,0.0014680731542317,0.0219902883091403,0.0250801604548686
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23412.Phospholipids in VLDL,41843,0.0455376067045798,0.00533122541128771,0.0350884048984559,0.0559868085107038,1.4661805781611e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23413.Phospholipids in LDL,41843,0.0212430517393521,0.00506854632507083,0.0113087009422132,0.0311774025364909,2.79342167520164e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23414.Phospholipids in HDL,41843,-0.030294663518102,0.00552016798692864,-0.0411141927724821,-0.0194751342637219,4.1399203835569e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23415.Total Esterified Cholesterol,41843,0.0116688142536183,0.0052354700925158,0.00140729287228737,0.0219303356349493,0.0258439490036489
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,41843,0.0440231577503244,0.00524021328824235,0.0337523397053694,0.0542939757952794,4.87364312307135e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,41843,0.0211066573304835,0.00504915544611395,0.0112103126561002,0.0310030020048669,2.9307916348496e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,41843,-0.0454006481293264,0.00576196153643162,-0.0566940927407324,-0.0341072035179205,3.54602339981113e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23419.Total Free Cholesterol,41843,0.0227391155323611,0.00514136089480819,0.0126620481785371,0.0328161828861852,9.82151256869729e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23420.Free Cholesterol in VLDL,41843,0.0448961933496584,0.00530774922700045,0.0344930048647375,0.0552993818345793,2.98726528602781e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23421.Free Cholesterol in LDL,41843,0.0134824829866998,0.00508159372616544,0.00352255928341554,0.0234424066899841,0.00798278296475778
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23422.Free Cholesterol in HDL,41843,-0.0235840039071051,0.00573186833120009,-0.0348184658362573,-0.0123495419779529,3.9029878142113e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,41843,0.0222741099817043,0.00502795970488168,0.0124193089601362,0.0321289110032724,9.49673389918029e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23424.Total Lipids in VLDL,41843,0.0416473555661573,0.00534014964651023,0.0311806622589972,0.0521140488733173,6.70982895704236e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23425.Total Lipids in LDL,41843,0.0216758378700012,0.00505095187087785,0.0117759722030806,0.0315757035369218,1.78782239336332e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23426.Total Lipids in HDL,41843,-0.0324107303371017,0.00560922173815681,-0.043404804943889,-0.0214166557303143,7.72417302826231e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,41843,-0.0240149953500772,0.00532146494109138,-0.0344450666346163,-0.0135849240655381,6.45119366628668e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23428.Concentration of VLDL Particles,41843,0.0459599070342612,0.00525994669228559,0.0356504115173814,0.0562694025511409,2.66193593321271e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23429.Concentration of LDL Particles,41843,0.0335412340939879,0.00507400188929549,0.0235961903909687,0.043486277797007,3.97940776821874e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23430.Concentration of HDL Particles,41843,-0.0320214128091018,0.00532405732005728,-0.0424565651564141,-0.0215862604617896,1.85224870506976e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,41843,0.0189913348025388,0.00554683290242276,0.00811954231379019,0.0298631272912874,0.000619354464573675
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23432.Average Diameter for LDL Particles,41843,0.00145525276270589,0.00525968983892434,-0.00885373932158581,0.0117642448469976,0.782029888634926
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23433.Average Diameter for HDL Particles,41843,-0.0194966013337592,0.00578402714698372,-0.0308332945418473,-0.00815990812567112,0.0007517374979312
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23434.Phosphoglycerides,41834,0.00210972137194944,0.00525143296853615,-0.00818308724638141,0.0124025299902803,0.687880372098099
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,41834,0.0435735670429735,0.00566984683556563,0.0324606672452649,0.0546864668406821,1.63568886726115e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23436.Total Cholines,41834,0.00198535644595867,0.00533913805982557,-0.00847935415129944,0.0124500670432168,0.710010772278926
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23437.Phosphatidylcholines,41834,0.000625072655166836,0.00536181636568159,-0.00988408742156908,0.0111342327319028,0.907195823418477
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23438.Sphingomyelins,41834,0.00834320341225344,0.00538588063201619,-0.00221312262649829,0.0188995294510052,0.121384463208078
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23439.Apolipoprotein B,41843,0.0348410160082533,0.00509191227688277,0.024860867945563,0.0448211640709435,8.12887165575418e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23440.Apolipoprotein A1,41843,-0.0330882685409776,0.00548781257373797,-0.043844381185504,-0.0223321558964512,1.68938325217573e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,41843,0.0494634803669491,0.00519758420744749,0.039276215320352,0.0596507454135461,2.09408867756671e-21
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23442.Total Fatty Acids,41834,0.0236291019060835,0.00490396869346583,0.0140173232668905,0.0332408805452765,1.46346513228249e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23443.Degree of Unsaturation,41834,-0.036342089072817,0.00533309974561786,-0.046794964574228,-0.025889213571406,9.87277822946607e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23444.Omega-3 Fatty Acids,41834,-0.00491473931959837,0.00517040214374491,-0.0150487275213384,0.00521924888214164,0.34184888731654
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23445.Omega-6 Fatty Acids,41834,0.0144823489822718,0.00507549332858244,0.00453438205825019,0.0244303159062934,0.00433229549636211
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,41834,0.0117859309172218,0.00509959924017666,0.00179071640647557,0.0217811454279681,0.0208399452239559
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,41834,0.0314199160792374,0.00499936109486604,0.0216211683332999,0.0412186638251748,3.3860391228616e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23448.Saturated Fatty Acids,41834,0.0235080654357735,0.00483906064276836,0.0140235065759476,0.0329926242955995,1.1994661887463e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23449.Linoleic Acid,41834,0.0195907868259758,0.00506844620616609,0.0096566322618903,0.0295249413900614,0.000111507814541773
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23450.Docosahexaenoic Acid,41834,-0.0172754007758154,0.00513876284645276,-0.0273473759548628,-0.00720342559676802,0.000776604922791648
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,41834,-0.0218886825971028,0.00519047795698056,-0.0320620193927847,-0.0117153458014209,2.49127248613607e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,41834,-0.0261906142482516,0.00509325413606244,-0.036173392354934,-0.0162078361415692,2.75392304370705e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,41834,-0.0343074856258617,0.00521436851003732,-0.0445276479055348,-0.0240873233461886,4.90081197930809e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,41834,0.0408506367359308,0.00547914149344238,0.0301115194087838,0.0515897540630779,9.49729605574934e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,41834,0.0135698906969855,0.00474275227031827,0.00427409624716167,0.0228656851468093,0.00422722256566768
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,41834,-0.00765328076218103,0.00522747245757061,-0.0178991267790194,0.00259256525465737,0.143204054466047
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,41834,-0.0315788482153575,0.0050839099981936,-0.0415433118118169,-0.021614384618898,5.40432789076775e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,41834,-0.0401452379595787,0.00542569785905956,-0.0507796057633354,-0.0295108701558219,1.45381094456075e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,41834,0.012386371198258,0.00512443690657964,0.00234247486136189,0.0224302675351541,0.015657354138001
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23460.Alanine,41840,0.00593928052736399,0.00510986652469768,-0.00407605786104347,0.0159546189157715,0.245128008162619
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23461.Glutamine,41805,-0.000473745674335166,0.00503962856864153,-0.0103514176688726,0.00940392632020224,0.925107337651596
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23462.Glycine,41829,0.0156288886672845,0.00608181363053794,0.00370853395143014,0.0275492433831389,0.0101873266134184
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23463.Histidine,41826,-0.00447694636536456,0.00506443852045216,-0.0144032458654508,0.00544935313472166,0.376714124055097
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),41833,-0.011535725420193,0.00567174420163836,-0.0226523440554042,-0.000419106784981827,0.0419822089232112
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23465.Isoleucine,41841,-0.0142743678306109,0.00547373084899332,-0.0250028802946378,-0.00354585536658399,0.00912297824997301
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23466.Leucine,41841,-0.0150513572024477,0.00561778180557439,-0.0260622095413735,-0.00404050486352189,0.0073881804763904
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23467.Valine,41833,-0.00670411717453088,0.00563686023564283,-0.0177523632363908,0.00434412888732907,0.234329067475315
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23468.Phenylalanine,41835,0.00694063184842854,0.00520434763496264,-0.00325988951609823,0.0171411532129553,0.182350760812383
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23469.Tyrosine,41829,0.00452216510697387,0.00540498875986804,-0.00607161286236748,0.0151159430763152,0.402795991259636
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23470.Glucose,41821,-0.012256094366387,0.00490769311662515,-0.0218751728749723,-0.00263701585780171,0.0125255582084525
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23471.Lactate,41823,0.0199356290803781,0.00518827093266816,0.00976661805234855,0.0301046401084078,0.000122385806614471
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23472.Pyruvate,41803,0.0182021293407005,0.00498463751923552,0.00843223980299885,0.0279720188784021,0.0002615724862542
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23473.Citrate,41841,0.00745119443946501,0.00514470886970574,-0.00263243494515824,0.0175348238240883,0.147550728665288
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23474.3-Hydroxybutyrate,41571,0.00194099006353565,0.00568450838688432,-0.00920064637475762,0.0130826265018289,0.732768427594922
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23475.Acetate,41831,-0.0228548003722479,0.00491703718283614,-0.0324921932506068,-0.0132174074938891,3.38268825527418e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23476.Acetoacetate,41842,-0.0109839887474721,0.00516499368512916,-0.0211073763703252,-0.000860601124618906,0.0334699489622363
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23477.Acetone,41842,-0.0158491071217937,0.00513911614529746,-0.0259217747665768,-0.00577643947701073,0.00204648212985685
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23478.Creatinine,41597,0.0278838165808995,0.00618566560900274,0.0157599119872542,0.0400077211745449,6.60720713762598e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23479.Albumin,41841,-0.0336672542507135,0.0051106248993897,-0.0436840790535173,-0.0236504294479097,4.6358225873241e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23480.Glycoprotein Acetyls,41843,0.044679952352618,0.00530619029397015,0.0342798193764366,0.0550800853287995,4.13703455079085e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,41843,0.0340093337726135,0.00540572776404748,0.0234141073550805,0.0446045601901466,3.24620338648987e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,41843,0.0312615886888922,0.00537536140413567,0.0207258803367863,0.0417972970409981,6.1767519026413e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,41843,0.0344061724871405,0.00555398789021326,0.0235203562223225,0.0452919887519585,6.00645381192069e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,41843,0.0366581736661513,0.00546094006938373,0.0259547311301592,0.0473616162021434,1.98708441461548e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,41843,0.0386157401527732,0.0054607433985608,0.027912683091594,0.0493187972139524,1.60938155183014e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,41843,0.0339067815886133,0.00542381870855571,0.0232760969198441,0.0445374662573825,4.19116926548808e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,41843,0.0283932111010136,0.00527039038778731,0.0180632459409505,0.0387231762610767,7.27444200153353e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,41843,0.0399332249019316,0.00563025574016002,0.028897923651218,0.0509685261526453,1.38285745707481e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,41843,0.0385132660462436,0.00559020685217514,0.0275564606159804,0.0494700714765069,5.85532037605357e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,41843,0.0416782879067088,0.00558553908905722,0.0307306312921567,0.0526259445212609,9.0652207701987e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,41843,0.0454693125477218,0.00554516501430288,0.0346007891196882,0.0563378359757555,2.62797043721552e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,41843,0.0462807969436551,0.00553378092219641,0.0354345863361501,0.05712700755116,6.70293357492958e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,41843,0.0429804351271128,0.00553733347395635,0.0321272615181584,0.0538336087360673,8.97574871577472e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,41843,0.0332390908180003,0.00560877141219291,0.0222458988501022,0.0442322827858984,3.17596895119436e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,41843,0.039812472409098,0.00554605715179742,0.0289422003915751,0.050682744426621,7.42268860353597e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23496.Total Lipids in Large VLDL,41843,0.0376404977994294,0.00553045797429412,0.0268008001698129,0.0484801954290458,1.04642687160212e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23497.Phospholipids in Large VLDL,41843,0.0423476496135711,0.00563822147631624,0.0312967355199913,0.0533985637071509,6.25188232422515e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23498.Cholesterol in Large VLDL,41843,0.0454077928299401,0.00556583493890306,0.0344987563496901,0.0563168293101901,3.70203980455467e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,41843,0.0472170235750957,0.00552182495951284,0.0363942466544505,0.0580398004957409,1.35327020068048e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,41843,0.0426606248344265,0.00562036656147818,0.0316447063739293,0.0536765432949237,3.40309496592129e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23501.Triglycerides in Large VLDL,41843,0.0303337101077222,0.00545598805759025,0.0196399735148453,0.0410274467005991,2.75450931261471e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,41843,0.0391420198860796,0.00521126763088428,0.0289279353295464,0.0493561044426128,6.241464464661e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,41843,0.0382105420305098,0.00522932078245763,0.0279610732968928,0.0484600107641267,2.88853421698366e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,41843,0.0396287870089548,0.00519736269493952,0.0294419561268733,0.0498156178910362,2.6105967920386e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,41843,0.0327733701256466,0.00510838550728753,0.022760934531363,0.0427858057199301,1.45038643475451e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,41843,0.0272912810679353,0.00509997288625729,0.017295334210871,0.0372872279249996,8.87991017296259e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,41843,0.0381095837406119,0.00516949706888159,0.027977369485604,0.0482417979956198,1.78046220311063e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,41843,0.0335588795888421,0.00538477636102623,0.0230047179212307,0.0441130412564535,4.73945199453185e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,41843,0.0459627697279898,0.00538620704805519,0.0354058039138016,0.056519735542178,1.57413189514166e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23510.Total Lipids in Small VLDL,41843,0.0454690097807646,0.0053893956995215,0.0349057942097024,0.0560322253518267,3.59851293137187e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23511.Phospholipids in Small VLDL,41843,0.0425551641602293,0.00527766487241604,0.0322109410102939,0.0528993873101648,8.06345857772357e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23512.Cholesterol in Small VLDL,41843,0.0447625253362895,0.00532147947426777,0.0343324255667247,0.0551926251058543,4.45311163491721e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,41843,0.0483512640880827,0.00541657769895048,0.0377347717981397,0.0589677563780256,4.96782620587796e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,41843,0.0383512684452589,0.00517666716341423,0.028205000804967,0.0484975360855508,1.35480887278296e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23515.Triglycerides in Small VLDL,41843,0.037979498561654,0.00545048377400173,0.0272965503646106,0.0486624467586974,3.36450908576467e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,41843,0.0463697080649099,0.00514802077493009,0.0362795873460469,0.0564598287837729,2.39765846140518e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,41843,0.0474000700258654,0.0051855598769551,0.0372363726670334,0.0575637673846974,7.09193622378937e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,41843,0.0514258289586199,0.00516805340077908,0.0412964442930929,0.0615552136241469,3.02124925033752e-23
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,41843,0.0387883572871487,0.00522052441626261,0.028556129431274,0.0490205851430234,1.15271095155175e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,41843,0.0348296403710649,0.00525986114394339,0.0245203125289359,0.045138968213194,3.68591655292444e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,41843,0.046619664877435,0.0051725030750111,0.0364815588504133,0.0567577709044568,2.27712479929276e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,41843,0.0438674979140761,0.00528939766749003,0.0335002784857957,0.0542347173423566,1.2053271029342e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23523.Concentration of IDL Particles,41843,0.0279968805153012,0.0051073431918203,0.0179864878593334,0.0380072731712689,4.28988980691615e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23524.Total Lipids in IDL,41843,0.0221546382605672,0.0052173249184462,0.0119286814204126,0.0323805951007217,2.18754149445258e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23525.Phospholipids in IDL,41843,0.0279020789552934,0.00521329846065548,0.0176840139724087,0.0381201439381782,8.83901419735232e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23526.Cholesterol in IDL,41843,0.0157638995163116,0.00524717710760756,0.00547943238540073,0.0260483666472224,0.00266722993346645
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,41843,0.014363571387191,0.00525467870700426,0.0040644011214627,0.0246627416529194,0.00627517039327373
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23528.Free Cholesterol in IDL,41843,0.0193125919280554,0.00520876092669328,0.00910342051173657,0.0295217633443742,0.000209992666575564
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23529.Triglycerides in IDL,41843,0.0438103150541355,0.00510515795318244,0.0338042054658979,0.0538164246423731,1.03915057933861e-17
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23530.Concentration of Large LDL Particles,41843,0.0327359666720964,0.00505452206789587,0.0228291034190205,0.0426428299251723,9.714510560348e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23531.Total Lipids in Large LDL,41843,0.0190376120050105,0.00507680782709856,0.00908706866389731,0.0289881553461237,0.000177645767264143
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23532.Phospholipids in Large LDL,41843,0.0177907279558926,0.00509332218902824,0.00780781646539727,0.027773639446388,0.000479271832493303
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23533.Cholesterol in Large LDL,41843,0.0165559172544623,0.00508044511178347,0.0065982448353667,0.0265135896735579,0.00112185072283214
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,41843,0.0178027509806772,0.00507191326189482,0.0078618009873634,0.0277437009739911,0.000449483979050693
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,41843,0.0129112326059931,0.00512732873615452,0.00286166828313023,0.0229607969288559,0.0118099803732053
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23536.Triglycerides in Large LDL,41843,0.0410471941650356,0.00504486558728834,0.0311592576139505,0.0509351307161208,4.43194196012279e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,41843,0.0310017534298736,0.00510509625501695,0.0209957647700404,0.0410077420897068,1.29214059854567e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23538.Total Lipids in Medium LDL,41843,0.0241759853913856,0.00507450578863683,0.0142299540456574,0.0341220167371138,1.91611933114326e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23539.Phospholipids in Medium LDL,41843,0.0226433610881157,0.00509513839593414,0.0126568898320848,0.0326298323441466,8.89727136603182e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23540.Cholesterol in Medium LDL,41843,0.0225150809042978,0.00506756442668904,0.0125826546279873,0.0324475071806083,8.94417445851763e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,41843,0.0253545602431005,0.00508655893065879,0.0153849047390093,0.0353242157471917,6.28687592438618e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,41843,0.0136351871237281,0.00504794780643289,0.00374120942311968,0.0235291648243366,0.0069191263099688
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23543.Triglycerides in Medium LDL,41843,0.038779597575516,0.00508305693161374,0.028816805989553,0.0487423891614789,2.5234003268838e-14
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23544.Concentration of Small LDL Particles,41843,0.0363867134687595,0.00510929659085958,0.0263724921506748,0.0464009347868443,1.12132884356211e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23545.Total Lipids in Small LDL,41843,0.0294312516636376,0.00503887024439793,0.0195550659846176,0.0393074373426575,5.31565141584744e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23546.Phospholipids in Small LDL,41843,0.0313160187577639,0.0050249097328156,0.0214671956814453,0.0411648418340824,4.74010233427645e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23547.Cholesterol in Small LDL,41843,0.0257503143207133,0.00505415728688359,0.0158441660384215,0.0356564626030051,3.5376854161792e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,41843,0.028605587654078,0.00505548996346377,0.018696827325689,0.038514347982467,1.56028451301584e-08
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,41843,0.0160750162325282,0.00506055180346134,0.006156334697744,0.0259936977673125,0.00149388143944176
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23550.Triglycerides in Small LDL,41843,0.0382504112151775,0.00515230887738919,0.0281518858154947,0.0483489366148603,1.20629331612208e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,41843,0.0117272849195915,0.00589719351902119,0.000168785622309969,0.023285784216873,0.0467635597983334
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,41843,0.00585333587263349,0.00591979063558943,-0.00574945377312179,0.0174561255183888,0.322791726140977
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,41843,0.00353895256016271,0.00588950152707214,-0.00800447043289869,0.0150823755532241,0.547922408487838
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,41843,0.00322984885155988,0.00598980025313154,-0.00851015964457794,0.0149698573476977,0.589740814165462
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,41843,-0.00176048322950756,0.00601959350598238,-0.013558886501233,0.0100379200422179,0.7699404206927
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,41843,0.0188392026707579,0.00582039871109892,0.00743122119700405,0.0302471841445118,0.00121194582273794
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,41843,0.0353511055080356,0.00492185305350762,0.0257042735231607,0.0449979374929105,7.2115399700997e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23558.Concentration of Large HDL Particles,41843,-0.0243348808352121,0.005937484814865,-0.0359723510723475,-0.0126974105980767,4.18284848462824e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23559.Total Lipids in Large HDL,41843,-0.0270850301181939,0.00588624814455889,-0.0386220764815294,-0.0155479837548585,4.23539278933006e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23560.Phospholipids in Large HDL,41843,-0.0292360779412351,0.00582646163868693,-0.0406559427530615,-0.0178162131294087,5.29417399596007e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23561.Cholesterol in Large HDL,41843,-0.0280978522363002,0.00597787598114723,-0.0398144891593488,-0.0163812153132517,2.62387624786278e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,41843,-0.0308960955426953,0.00599849553144455,-0.0426531467843266,-0.019139044301064,2.63324985122209e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,41843,-0.0184287958604971,0.00590892787687722,-0.0300102944991765,-0.00684729722181778,0.00181975319144096
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23564.Triglycerides in Large HDL,41843,0.0181961194010935,0.00518719239254486,0.00802922231170557,0.0283630164904814,0.000453166993816838
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,41843,-0.0375944324086705,0.00542729116185026,-0.048231923085897,-0.026956941731444,4.49953662117408e-12
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23566.Total Lipids in Medium HDL,41843,-0.0353375791697736,0.0053383127272782,-0.0458006721152388,-0.0248744862243083,3.74008809069665e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23567.Phospholipids in Medium HDL,41843,-0.0310967181386869,0.00525066821247827,-0.0413880278351444,-0.0208054084422295,3.25082617611532e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23568.Cholesterol in Medium HDL,41843,-0.0454042649783642,0.0054851751167896,-0.0561552082072718,-0.0346533217494566,1.37603074557065e-16
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,41843,-0.0477849258514147,0.00547668766354129,-0.0585192336719556,-0.0370506180308737,2.97281928247538e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,41843,-0.0339739720566836,0.00551495278380224,-0.044783279512936,-0.0231646646004312,7.4692323029474e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23571.Triglycerides in Medium HDL,41843,0.0223841072180919,0.00532388977671898,0.0119492832557227,0.0328189311804611,2.63419916589919e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23572.Concentration of Small HDL Particles,41843,-0.021440300516682,0.00508267596503531,-0.0314023454081512,-0.0114782556252128,2.47778208477056e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23573.Total Lipids in Small HDL,41843,-0.0181746975259153,0.00508164967955928,-0.0281347308978515,-0.00821466415397914,0.000349419939398132
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23574.Phospholipids in Small HDL,41843,-0.0189014442629928,0.00505606009635193,-0.0288113220518426,-0.00899156647414306,0.000185993731395167
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23575.Cholesterol in Small HDL,41843,-0.0258615130448386,0.00505576024373638,-0.0357708031225619,-0.0159522229671153,3.17693266289202e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,41843,-0.030695108429161,0.00508614028487177,-0.0406639433875097,-0.0207262734708124,1.63157720479716e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,41843,-0.00863108297562059,0.00504344247358882,-0.0185162302238547,0.00125406427261349,0.0870403877651095
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23578.Triglycerides in Small HDL,41843,0.0357539016024756,0.00573174863146549,0.0245196742848032,0.0469881289201479,4.57068230431049e-10
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,0.0041264276097619,0.00575549282240081,-0.0071543383221437,0.0154071935416675,0.473415066528833
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,-0.000337892235595032,0.00552891160579849,-0.0111745589829601,0.01049877451177,0.951269609227413
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,0.00520232348305985,0.00559887895675134,-0.00577147927217278,0.0161761262382925,0.352817210850983
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,-0.00927377543299863,0.00552265543606997,-0.0200981800876958,0.00155062922169851,0.0931326836786974
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41465,-0.00149338587817553,0.0055957116901309,-0.0124609807908321,0.00947420903448104,0.78956551126795
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,41771,0.0409883686486385,0.005622387401501,0.0299684893416966,0.0520082479555805,3.27129926607226e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,41771,6.26005721107511e-05,0.00569602115067374,-0.0111016008832098,0.0112268020274313,0.991231409598271
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,41771,-0.00449450722072564,0.00566002662340907,-0.0155881594026074,0.00659914496115614,0.427163857584942
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,41771,0.0169368153044048,0.00571198637913538,0.00574132200129943,0.0281323086075101,0.00303091614577658
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,41771,-0.0113768240827922,0.00567384554372029,-0.022497561348484,-0.000256086817100444,0.0449690810995071
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,41843,0.0509417838013126,0.00586695843008988,0.0394425452783364,0.0624410223242887,4.30818861261981e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,41843,0.0168813912553503,0.00549349037085017,0.00611415012848393,0.0276486323822166,0.00212362506225346
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,41843,0.0117748155789983,0.00558868197964808,0.000820998898888101,0.0227286322591086,0.0351446716836376
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,41843,0.0269985918674746,0.00556900183872559,0.0160833482635725,0.0379138354713768,1.26120087158084e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,41843,-0.0323945439233902,0.00559643834388726,-0.0433635630774093,-0.0214255247693712,7.26608576448923e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,41843,0.0171987951130368,0.00538747887267185,0.0066393365226,0.0277582537034737,0.00141442993619506
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,41843,0.000291215264170632,0.0055875754592503,-0.01066043263596,0.0112428631643012,0.958435170499161
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,41843,-0.00320979107558744,0.00562565917478853,-0.014236083058173,0.00781650090699807,0.568305814843224
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,41843,0.00974881579593815,0.00546143627447203,-0.000955599302027023,0.0204532308939033,0.0742796821189986
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,41843,-0.00416250246194544,0.00553841053415605,-0.0150177871088913,0.00669278218500042,0.4523231267434
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,41843,-0.00623231490969495,0.00544154415859035,-0.016897741460532,0.00443311164114214,0.252096898545475
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,41843,0.00657629017773546,0.00525265274294091,-0.00371890919842872,0.0168714895538996,0.210594129992212
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,41843,0.0146491725694092,0.00517363719051922,0.00450884367599151,0.0247895014628269,0.00463995596499526
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,41843,-0.00519777563042489,0.00548900937499783,-0.0159562340054206,0.00556068274457085,0.343685416179577
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,41843,-0.00292483926644789,0.00530615275628561,-0.0133248986687677,0.00747522013587191,0.581494529118528
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,41843,0.0399771155513007,0.00514342998857489,0.029895992773694,0.0500582383289075,8.26343221671722e-15
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,41843,-0.0121497871901149,0.00543473943826197,-0.0228018764891083,-0.0014976978911214,0.0253959855708506
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,41843,-0.0153569779304229,0.00550993235662091,-0.0261564453493999,-0.00455751051144596,0.00532504847542512
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,41843,0.00980433916235586,0.00479355420495247,0.000408972920649019,0.0191997054040627,0.0408433089544748
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,41843,0.00450834810687456,0.00536723182956126,-0.00601142627906551,0.0150281224928146,0.400936778919983
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,41843,0.0297658443069895,0.00503388948267914,0.0198994209209384,0.0396322676930406,3.44020267251791e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,41843,-0.0276361709875103,0.00527846115694505,-0.0379819548551226,-0.017290387119898,1.66921497777823e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,41843,-0.0313021363461061,0.00520173631124821,-0.0414975395161526,-0.0211067331760596,1.81659474858271e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,41843,-0.00336559986739679,0.0048457071932289,-0.0128631859661254,0.00613198623133186,0.487347737531026
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,41843,0.0223346176242193,0.00531639775852342,0.0119144780175134,0.0327547572309252,2.67383338123841e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,41843,-0.0137121869946484,0.00515233730042626,-0.0238107681034839,-0.00361360588581293,0.00779212753352009
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,41843,-0.0179038412770689,0.00525328163268901,-0.0282002732771393,-0.00760740927699841,0.000656056343327282
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,41843,-0.00500652171996462,0.00501551128490831,-0.0148369238383849,0.00482388039845567,0.318196917411033
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,41843,-0.0237912421760646,0.00563698745106961,-0.034839737580161,-0.0127427467719681,2.45320976170195e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,41843,0.0230488050214421,0.00517124790133931,0.0129131591348171,0.0331844509080672,8.37553873785573e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,41843,-0.0222237273446983,0.00528712325703411,-0.0325864889284852,-0.0118609657609115,2.64697856123793e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,41843,-0.00842518843635595,0.00522310207538013,-0.018662468504101,0.00181209163138911,0.106754825822317
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,41843,0.0224407031156403,0.00528766787580569,0.0120768740790612,0.0328045321522195,2.21094945888258e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,41843,-0.032201923629362,0.0054424057481503,-0.0428690388957365,-0.0215348083629874,3.3626251900208e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,41843,0.0194984024465388,0.00515435577952625,0.00939586511866738,0.0296009397744103,0.000155695107280218
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,41843,-0.00102421398609122,0.00526420098249892,-0.0113420479117891,0.00929361993960666,0.845738762016767
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,41843,-0.0154947181754388,0.00513067798089866,-0.0255508470180002,-0.0054385893328774,0.00253244957920509
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,41843,0.00945557344241952,0.00521794199906824,-0.000771592875754226,0.0196827397605933,0.0699892178844342
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,41843,-0.0270089130215406,0.00517281913273268,-0.0371476385216967,-0.0168701875213846,1.80347457208199e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,41843,0.0209689285606057,0.00526509549948489,0.0106493413816153,0.0312885157395961,6.85211109734108e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,41831,-0.00144166006449913,0.00561275948962714,-0.0124426686641683,0.00955934853517007,0.797295429369869
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,41831,-0.0123335865714804,0.00488097008419255,-0.0219002879364978,-0.00276688520646302,0.0115199002463252
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,41831,-0.0232411492913583,0.0045335122916947,-0.03212683338308,-0.0143554651996367,2.99308469006026e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,41831,0.0149028833323241,0.00581298068490066,0.00350944118991879,0.0262963254747294,0.0103665047739071
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,41831,0.0249778255502682,0.00548281205681396,0.0142315139189129,0.0357241371816236,5.26882991194829e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,41843,-0.00923641049742934,0.00518096996275764,-0.0193911116244343,0.000918290629575639,0.0746487673898593
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,41843,-0.0189335452171419,0.00546690145946721,-0.0296486720776976,-0.00821841835658616,0.000535270477353989
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,41843,-0.0241551303018909,0.00525672893705404,-0.0344583190185168,-0.013851941585265,4.36561194575881e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,41843,0.02199375905655,0.00521836452839115,0.0117657645809034,0.0322217535321966,2.51786349151011e-05
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,41843,0.0354271043308911,0.00524253402797279,0.0251517376360644,0.0457024710257178,1.46135154673577e-11
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,41843,0.0410983505999212,0.00558939226541407,0.0301431417597097,0.0520535594401328,2.05309461572691e-13
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,41843,-0.0495361989050057,0.00557978205948601,-0.0604725717415983,-0.0385998260684132,7.68702946545938e-19
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,41843,-0.0469134536247798,0.00530259142423269,-0.0573065328162759,-0.0365203744332838,1.00933543910007e-18
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,41843,-0.0213638912512458,0.00581267015185063,-0.032756724748873,-0.00997105775361852,0.000238414163575753
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,41843,0.050424748831508,0.00550087095120431,0.0396430417671476,0.0612064558958685,5.58783397142439e-20
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,41843,-0.00840956013061485,0.00511938805472093,-0.0184435607178679,0.00162444045663817,0.1004711308376
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,41843,-0.0243741376503225,0.00507480059777655,-0.0343207468219645,-0.0144275284786805,1.58037627734714e-06
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,41843,-0.0301844227703464,0.00500047190000728,-0.0399853476943607,-0.0203834978463322,1.61887594942234e-09
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,41843,0.0271365960783504,0.00541994038117538,0.0165135129312466,0.0377596792254541,5.60520887387983e-07
SFTPA2,Pulmonary surfactant-associated protein A2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,41843,0.05338547157509,0.00572844626699772,0.0421577168917744,0.0646132262584055,1.35307314894529e-20
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51406,0.000608671373350618,0.00435102398111917,-0.00791933562964296,0.0091366783763442,0.888746934069349
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51406,0.00120040669467988,0.00422083205867066,-0.00707242414031462,0.00947323752967438,0.776106067636684
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49898,-0.000137674525668548,0.0040306243279981,-0.00803769820854482,0.00776234915720772,0.9727521785955
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49898,0.00539836446408219,0.00438956512308809,-0.00320518317717046,0.0140019121053348,0.218778999024708
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49898,-0.00201804944534871,0.00434691306202682,-0.0105379990469213,0.00650190015622385,0.642474202085472
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49898,0.00158447453274774,0.00400029300840333,-0.00625609976372279,0.00942504882921827,0.692042884227786
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24009.Traffic intensity on the nearest road,51406,-0.0390137754768257,0.0469116390484867,-0.13096058801186,0.0529330370582082,0.405618718473027
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24010.Inverse distance to the nearest road,51406,-0.000477677998385365,0.00380409955919848,-0.00793371313441439,0.00697835713764366,0.900073997497037
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24011.Traffic intensity on the nearest major road,51406,0.00360369277645948,0.00379243612158983,-0.0038294820218566,0.0110368675747756,0.342004637175572
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24012.Inverse distance to the nearest major road,51406,-0.000708363291887362,0.00384481714710295,-0.00824420490020914,0.00682747831643442,0.853828006474318
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24013.Total traffic load on major roads,51406,-0.0155080903755937,0.0325343420950953,-0.0792754008819806,0.0482592201307931,0.633602888230341
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24015.Sum of road length of major roads within 100m,51406,-0.0425463165386921,0.0317990691356408,-0.104872492044548,0.0197798589671638,0.180918368303521
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51406,-0.0026425956623566,0.0043733836010672,-0.0112144275204483,0.00592923619573511,0.545686703363256
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51406,-0.00116363138807953,0.0043726088465757,-0.0097339447273679,0.00740668195120885,0.790150480006732
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51406,-0.00373975341282458,0.0043218378331731,-0.0122105555658439,0.0047310487401947,0.386874729074446
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51369,-0.00807702250979511,0.00422771164984714,-0.0163633373434955,0.000209292323905288,0.0560820404896682
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24020.Average daytime sound level of noise pollution,51406,-0.00497433031837469,0.00380151132002407,-0.0124252925056219,0.00247663186887248,0.190712257050169
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24021.Average evening sound level of noise pollution,51406,-0.00493971376253951,0.00380139148404525,-0.0123904410712682,0.00251101354618918,0.193803074387748
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24022.Average night-time sound level of noise pollution,51406,-0.00496578546376953,0.00380164928254997,-0.0124170180575675,0.0024854471300284,0.191491361744349
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51406,-0.00494886794597303,0.00380156566883716,-0.0123999366568939,0.00250220076494781,0.192998833681851
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51406,-0.00495279069204276,0.00380161190392424,-0.0124039500237343,0.00249836863964875,0.192651650654641
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2405.Number of children fathered,51400,-0.0213609859553687,0.0245845373160013,-0.0695466790947313,0.0268247071839939,0.384922513203846
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48958,0.00691166140760099,0.00449568619809617,-0.0018998835406675,0.0157232063558695,0.12421128428931
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48958,-0.00243862865541707,0.00403944901690916,-0.010355948728559,0.00547869141772488,0.546047653786665
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24502.Water percentage, buffer 1000m",48958,-0.00128105221924285,0.00408062798310985,-0.00927908306613815,0.00671697862765244,0.753573572807405
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48958,0.00654675725933362,0.00421687735453971,-0.0017183223555642,0.0148118368742315,0.120555049510377
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48958,-0.00171728492386209,0.00407243865393312,-0.00969926468557102,0.00626469483784683,0.673259652512005
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24505.Water percentage, buffer 300m",48958,0.0063873637793129,0.00410035679233031,-0.00164933553365451,0.0144240630922803,0.119306159482375
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51486,0.00492047133600045,0.00432469078517649,-0.00355592260294546,0.0133968652749464,0.255231546075029
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51486,0.00814388972943759,0.00404344864438836,0.000218730386436411,0.0160690490724388,0.0440112379098959
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X24508.Distance (Euclidean) to coast,51486,0.000546696904883177,0.00382743526774932,-0.00695507621990549,0.00804847002967184,0.886420681293194
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2867.Age started smoking in former smokers,35345,-0.0272921526225669,0.00710851445682593,-0.0412248409579457,-0.013359464287188,0.000124483854269015
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36832,0.0328417755932847,0.0512653500094673,-0.0676383104252712,0.133321861611841,0.521785320336964
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36831,0.042241614328209,0.058199776290384,-0.0718299472009437,0.156313175857362,0.467979745045494
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36831,0.00202491121163652,0.0549291019693192,-0.105636128648229,0.109685951071502,0.970594268615205
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36821,0.00254836325949203,0.0549464822553826,-0.105146741961058,0.110243468480042,0.963009295651459
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28739.Difficulty with standing for long periods,36838,0.0981663657494936,0.0463757206842109,0.00726995320844026,0.189062778290547,0.0343099560409799
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28740.Difficulty with taking care of household responsibilities,36854,0.0564986685715235,0.053691162468271,-0.0487360098662878,0.161733347009335,0.292697374971962
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28741.Difficulty learning a new task,36806,0.037371160529806,0.0636173676188302,-0.0873188800031013,0.162061201062713,0.556926788949264
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28742.Difficulty with joining in community activities,36388,0.127538293969329,0.0582639067244831,0.0133410367893417,0.241735551149316,0.0286281798545132
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28743.Difficulty with being emotionally affected by health problems,36800,0.0397741515023778,0.0517190838553077,-0.0615952528540253,0.141143555858781,0.441890491679368
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36860,0.0587112378658056,0.0688769414493987,-0.0762875673750158,0.193710043106627,0.394012550099901
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34754,0.0654742916998052,0.0458917807376149,-0.0244735985459201,0.15542218194553,0.153714057240604
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2897.Age stopped smoking,35341,0.0644031535744483,0.00743605085868548,0.0498284938914248,0.0789778132574719,5.78777185112229e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35913,0.00678595748552757,0.0139431267390098,-0.0205425709229317,0.0341144858939868,0.626493780570716
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35913,-0.0337656816085002,0.0157921798536934,-0.0647183541217393,-0.0028130090952611,0.0325395079963829
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35913,0.111313757954426,0.0532919972986481,0.00686144324907594,0.215766072659776,0.0367645591832569
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35913,-0.0455625652000469,0.0522721829117039,-0.148016043706987,0.0568909133068927,0.383433001869103
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35913,0.00548395901935908,0.0641388391602087,-0.12022816573465,0.131196083773368,0.931865141983213
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35913,0.0535469484005713,0.0578774081344317,-0.0598927715429149,0.166986668344057,0.354903460325299
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35913,-0.0093984863399427,0.0236877863700601,-0.0558265476252605,0.0370295749453751,0.69155228483412
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35913,0.00131608773844709,0.044500234749883,-0.0859043723713235,0.0885365478482177,0.976406930883552
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29002.Recent lack of interest or pleasure in doing things,35871,0.0234784637466176,0.0564747184673508,-0.0872119844493899,0.134168911942625,0.677616890311371
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29003.Recent feelings of depression,35872,-0.00139627766190695,0.0562580712537584,-0.111662097319273,0.108869541995459,0.980199895281232
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35876,0.0548533802556005,0.043807644586557,-0.0310096031340513,0.140716363645252,0.210558479737047
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29005.Recent feelings of tiredness or low energy,35877,0.0736592468600155,0.0433453907843825,-0.0112977190773741,0.158616212797405,0.0892948920417214
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29006.Recent poor appetite or overeating,35883,0.0480982322893038,0.0685769484008827,-0.0863125865764263,0.182509051155034,0.483090752099836
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29007.Recent feelings of inadequacy,35860,0.0433151502791538,0.0612346634074906,-0.0767047899995278,0.163335090557835,0.479363482225386
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29008.Recent trouble concentrating on things,35878,0.0408623594705584,0.058388922359485,-0.0735799283540323,0.155304647295149,0.484055423494023
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35876,-0.0421890759979528,0.099974213513604,-0.238138534484617,0.153760382488711,0.673037796275243
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29010.Recent thoughts of suicide or self-harm,35856,0.237559947906686,0.103962068887447,0.0337942928872894,0.441325602926083,0.022337824411078
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#0.Substances taken for depression_None of options listed,35800,-0.0383314601595904,0.028974819613319,-0.0951221066016956,0.0184591862825147,0.185902942837598
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35800,-0.0771333994964761,0.052387217975584,-0.179812346728621,0.0255455477356685,0.14096453730223
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35800,-0.00218812101317278,0.0315761799348542,-0.0640774336854869,0.0597011916591414,0.944755479034121
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35800,-0.0723463565617252,0.0956954693169949,-0.259909476423035,0.115216763299585,0.44967028390659
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35800,0.0850586427579556,0.0624255878712026,-0.0372955094696016,0.207412794985513,0.173063669081844
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35800,-0.0248083393119887,0.0714838056615413,-0.16491659840861,0.115299919784632,0.728565112017199
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35800,0.0373918907750017,0.0764657655451711,-0.112481009693534,0.187264791243537,0.624855374969525
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35800,-0.124466689969235,0.0894933097422326,-0.299873577064011,0.0509401971255407,0.164331114950274
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35800,0.000140272169598367,0.0619456554097617,-0.121273212433535,0.121553756772731,0.998193303211418
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35800,-0.0610692642328954,0.0271989284457978,-0.114379163986659,-0.0077593644791317,0.0247802571327813
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35800,0.0368324917974513,0.0428640224713906,-0.0471809922464742,0.120845975841377,0.390210872613184
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35800,-0.0149809503849964,0.0698534844130584,-0.151893779834591,0.121931879064598,0.830192508777584
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35800,-0.0936286309036942,0.0844848068660146,-0.259218852361083,0.0719615905536943,0.267799345360804
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35800,0.00112449028965732,0.0507027872173051,-0.0982529726562607,0.100501953235575,0.982306520340099
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35800,0.00969335251757491,0.0786413309595028,-0.144443656163051,0.1638303611982,0.901904432880588
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35800,0.0325639017417836,0.0794887670674912,-0.123234081710499,0.188361885194066,0.682062640282841
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35800,0.013876395586106,0.0440071062197376,-0.0723775326045796,0.100130323776792,0.752526548238346
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35800,-0.00377670536720359,0.0416982059964113,-0.0855051891201697,0.0779517783857625,0.927834906166088
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35800,-0.065211163589706,0.0627907347916076,-0.188281003781257,0.057858676601845,0.299050086351953
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29058.Recent feelings or nervousness or anxiety,35765,0.0435296346173407,0.0546076049234007,-0.0635012710325246,0.150560540267206,0.425399036923944
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29059.Recent inability to stop or control worrying,35772,0.0320572583107289,0.0578236892454105,-0.0812771726102755,0.145391689231733,0.579324724751389
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29060.Recent worrying too much about different things,35771,0.025762443882425,0.0514739569306405,-0.0751265117016304,0.12665139946648,0.616742133827421
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29061.Recent trouble relaxing,35767,0.00880756636988702,0.0548875811447937,-0.0987720926739086,0.116387225413683,0.872518873902288
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29062.Recent restlessness,35774,-0.0203213636756326,0.0756550636754876,-0.168605288479588,0.127962561128323,0.788241030798642
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29063.Recent easy annoyance or irritability,35763,-0.00143930883153954,0.0528859967188234,-0.105095862400433,0.102217244737354,0.97828876242496
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29064.Recent feelings of foreboding,35766,0.0423596975559943,0.0652071705060419,-0.0854463566358478,0.170165751747836,0.515960366896346
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35800,0.00358169295905867,0.0341203628308765,-0.0632942181894592,0.0704576041075766,0.916400712778675
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35800,0.0731118285446446,0.0514454924847811,-0.0277213367255265,0.173944993814816,0.155316086806079
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35800,-0.0434383348421157,0.0721403498462416,-0.184833420540749,0.0979567508565178,0.547102267997989
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35800,-0.0558124024503735,0.0709146256983831,-0.194805068819204,0.0831802639184573,0.431286374695031
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#2.Symptoms of panic attack_Sweating,35800,-0.0145273927184767,0.0441801228054605,-0.101120433417179,0.0720656479802258,0.742299858659762
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35800,0.0181669802786411,0.0548351852819435,-0.0893099828739682,0.12564394343125,0.740426384457077
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35800,-0.0515831562765911,0.0523445000149339,-0.154178376305862,0.0510120637526793,0.324433672853208
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35800,-0.0426390793567437,0.0530050936962843,-0.146529063001461,0.0612509042879735,0.421173151798557
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35800,-0.027307917436769,0.0664878094194347,-0.157624023898861,0.103008189025323,0.681289593095107
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29076.Felt loved as a child,35734,-0.0427050519068836,0.0441438806921346,-0.129227058063467,0.0438169542497001,0.333373955201226
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29077.Physically abused by family as a child,35747,0.0837711609916749,0.0567728177828957,-0.0275035618628006,0.19504588384615,0.140108666074964
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29078.Felt hated by family member as a child,35740,0.181568585505639,0.0633350863281849,0.0574318163023967,0.305705354708881,0.0041586776069703
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29079.Sexually molested as a child,35724,-0.0895631158568446,0.0952750994125913,-0.276302310705524,0.0971760789918343,0.347225098922994
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29080.Someone to take to doctor when needed as a child,35735,-0.0865670881294653,0.0661575119784289,-0.216235811607186,0.0431016353482553,0.190746022876213
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35745,-0.0342387902365404,0.0975821552090746,-0.225499814446327,0.157022233973246,0.725695152750588
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35719,-0.0741114082905738,0.0837101744474888,-0.238183350207652,0.0899605336265043,0.376006779850036
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35756,-0.228429886897931,0.095821097502435,-0.416239238002703,-0.040620535793158,0.0171552153891011
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35749,0.224979786142222,0.276228110510703,-0.316427310458756,0.766386882743199,0.415402310453768
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35742,-0.0562183490841589,0.17916569228317,-0.407383105959172,0.294946407790854,0.753698410668407
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29086.Experienced a violent or sexual assault,35762,-0.12345510662191,0.103138588505033,-0.325606740091774,0.0786965268479539,0.231352919931643
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29087.Experienced a life-threatening injury or illness,35754,0.13561745954041,0.0497584889603473,0.0380908211781294,0.233144097902691,0.00643576790879678
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29088.Experienced a marital separation or divorce,35753,0.00726864206999078,0.0502050300612368,-0.0911332168500334,0.105670500990015,0.884889316428233
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29089.Experienced the death of a spouse or partner,35763,0.0532721054677661,0.0746140544605809,-0.0929714412749725,0.199515652210505,0.475269750812467
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35757,-0.0318808821822044,0.0614948908103826,-0.152410868170554,0.0886491038061455,0.604173342302212
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29091.Frequency of drinking alcohol,35748,-0.0783301198512502,0.0410696891533429,-0.158826710591802,0.00216647088930175,0.0565284217417556
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35168,-0.0162316656490009,0.0436928643044287,-0.101869679685681,0.0694063483876794,0.710281123136513
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35186,-0.0607263472478836,0.0437517490454828,-0.14647977537703,0.0250270808812627,0.165191536746222
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29104.Ever used cannabis,35744,0.0662615424180591,0.0546164146532354,-0.0407866303022823,0.1733097151384,0.225087137109495
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29108.Ever thought that life not worth living,35718,0.00189497128832575,0.055132004859362,-0.106163758236024,0.109953700812675,0.972581850739968
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29109.Ever contemplated self-harm,35722,-0.0635969376050584,0.0783642005209745,-0.217190770626168,0.0899968954160516,0.417073569130121
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29111.Ever self-harmed,35734,0.0598738786488015,0.133863131170251,-0.202497858444891,0.322245615742494,0.654688766171205
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35736,-0.0793785340143995,0.0843235338075289,-0.244652660277156,0.0858955922483572,0.346553901095725
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36383,-0.0713948642159845,0.0709824442583043,-0.210520454962261,0.0677307265302919,0.31453816368905
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36383,-0.124573920933365,0.0546542876660593,-0.231696324758841,-0.0174515171078882,0.0226757486592687
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36383,-0.0829161179773409,0.0690309154991226,-0.218216712355621,0.0523844764009394,0.229731629265933
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36383,-0.0342015141348623,0.115698891649004,-0.26097134176691,0.192568313497185,0.767537374570245
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35725,-0.0907719504817237,0.0472545208879597,-0.183390811422125,0.00184691045867737,0.0547822027694163
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X29153.Pain or discomfort today,35740,-0.00190994728802513,0.0428275054517733,-0.0858518579735009,0.0820319633974506,0.964430358019314
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29154.Anxiety or depression today,35740,0.0236134119961286,0.0570570658703413,-0.0882184371097404,0.135445261101998,0.678991967129997
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29166.Frequency of confiding in someone close,35568,-0.0968105265179464,0.0429643290730628,-0.181020611501149,-0.0126004415347433,0.0242726827775828
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35723,0.0323681819665907,0.013135648156362,0.0066223115801212,0.0581140523530601,0.0137573809172346
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35723,-0.0438348396351454,0.0135820160304637,-0.0704555910548543,-0.0172140882154365,0.00125478290679628
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35723,-0.00823322609309955,0.0144400001443257,-0.036535626375978,0.0200691741897789,0.568581736551336
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35723,0.0095245726710631,0.0200521051303574,-0.0297775533844374,0.0488266987265636,0.634807837496742
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35723,-0.116050751923593,0.0397506217396681,-0.193961970533342,-0.0381395333138432,0.00351725631291196
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35723,-0.00301485166528196,0.0146422016944297,-0.0317135669863642,0.0256838636558003,0.836873718126452
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35718,0.00843068296281115,0.015415719407166,-0.0217841270752342,0.0386454930008565,0.584472333475171
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35718,-0.0208969147324775,0.0242216241208108,-0.0683712980092667,0.0265774685443117,0.388310619065131
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35718,0.00402256427845386,0.0277300374058813,-0.0503283090370734,0.0583734375939811,0.88466632397328
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35718,-0.0157559158064614,0.0336409473772679,-0.0816921726659064,0.0501803410529836,0.639544873670061
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35718,-0.0153699607192661,0.0555583156030759,-0.124264259301295,0.0935243378627626,0.78206031851387
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35718,0.010141258392969,0.022383296947402,-0.033730003623939,0.054012520409877,0.65051027954603
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29171.Frequency of feeling 'in tune' with people,35543,0.0112887631573701,0.0527119689956433,-0.0920266960740908,0.114604222388831,0.830429052828681
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29172.Freuency of feeling that lacks companionship,35679,0.0160714610108868,0.0489537384675085,-0.0798778663854298,0.112020788407203,0.742695348228141
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29173.Frequency of feeling left out,35649,-0.00503966350212377,0.0513139476370286,-0.1056150008707,0.0955356738664523,0.921766467031159
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29174.Frequency of feeling isolated from others,35682,0.0110818491650721,0.0523785065934856,-0.0915800237581597,0.113743722088304,0.832446690359563
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29175.Tendency to bounce back quickly after hard times,35733,0.0304459999116982,0.0421920348014322,-0.052250388299109,0.113142388122505,0.470560783836605
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29176.Ability to make it through stressful events,35733,0.0011817414094337,0.0406798433215728,-0.0785507515008491,0.0809142343197165,0.976825683812792
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29177.Quick recovery from stressful events,35733,0.0771826439484683,0.0422327901886574,-0.00559362482130032,0.159958912718237,0.0676585034049605
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29178.Hard to snap back when something bad happens,35733,0.0124743698775357,0.0411586628707947,-0.0681966093492218,0.0931453491042933,0.761837694403405
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29179.Comes through difficult times with little trouble,35733,0.039161302808831,0.0420003273358078,-0.0431593387693523,0.121481944387014,0.351158985761837
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29180.Tendency to take a long time to get over setbacks,35733,-0.00281819386854427,0.041485094663751,-0.0841289794094962,0.0784925916724076,0.945841124806874
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29181.General happiness,35693,0.0533474050574293,0.042688655974842,-0.030322360653261,0.13701717076812,0.211455620947083
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,X29182.Belief that own life is meaningful,35597,-0.0817072239475533,0.043378908525692,-0.16672988465791,0.00331543676280306,0.0596645744085137
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34686,0.108029420444959,0.0410886588818432,0.0274956490365462,0.188563191853372,0.00858066588901375
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2946.Father's age,33423,-0.0282452044016249,0.0118478398646442,-0.0514669705363275,-0.00502343826692223,0.0171642318416285
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X2966.Age high blood pressure diagnosed,35363,-0.0154455090933859,0.00953909729139273,-0.0341421397845156,0.00325112159774388,0.105455312987052
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30000.White blood cell (leukocyte) count,51051,0.0359009399744211,0.0040627110147926,0.0279380263854276,0.0438638535634146,1.05683863056151e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51052,0.0224080549258021,0.00437322599391337,0.0138365319777318,0.0309795778738723,3.01727437154433e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30020.Haemoglobin concentration,51052,0.0191541137082679,0.0046029722691947,0.0101322880606463,0.0281759393558896,3.17689768722366e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30030.Haematocrit percentage,51052,0.0250340627428292,0.00451647439269721,0.0161817729331426,0.0338863525525157,3.00961583966734e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30040.Mean corpuscular volume,51052,-0.0016054889083036,0.00403118445420028,-0.00950661043853615,0.00629563262192894,0.690436956153809
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51052,-0.00919669981234729,0.00404870430949114,-0.0171321602589499,-0.00126123936574466,0.0231251328416246
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51052,-0.0155479180368043,0.00393198097442321,-0.0232546007466738,-0.00784123532693482,7.70201746858094e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51052,0.0437278389152249,0.00410814904452413,0.0356758667879577,0.0517798110424922,2.14587316473994e-26
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30080.Platelet count,51052,7.22263245987113e-05,0.0040285990097413,-0.00782382773449424,0.00796828038369166,0.985696133993489
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30090.Platelet crit,51052,0.00121472722035381,0.00410445939308977,-0.00683001319010215,0.00925946763080976,0.767268684123228
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51052,0.00208261357033865,0.00381625021391811,-0.00539723684894085,0.00956246398961816,0.585262131551414
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30110.Platelet distribution width,51052,0.00281815086054498,0.0039149915727494,-0.00485523262204383,0.0104915343431338,0.471633629094048
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30120.Lymphocyte count,51015,0.00643461119604939,0.00396098469897936,-0.00132891881395015,0.0141981412060489,0.104283655310641
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30130.Monocyte count,51015,0.0150952386536216,0.00395822997750111,0.00733710789771939,0.0228533694095237,0.000137305320815055
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30140.Neutrophill count,51015,0.0354280811198595,0.00401665550828855,0.0275554363236139,0.043300725916105,1.22323778650159e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30150.Eosinophill count,51015,0.00794508804613758,0.00383314469501239,0.000432124443913297,0.0154580516483619,0.038208474257096
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30160.Basophill count,51015,0.102413349481715,0.0242198700710642,0.0549424041424288,0.149884294821,2.36202871700249e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30170.Nucleated red blood cell count,51015,-0.0284801975573882,0.123485472900006,-0.2705117244414,0.213551329326624,0.817599689717229
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30180.Lymphocyte percentage,51016,-0.0215800557306886,0.00391355083337364,-0.029250615364101,-0.0139094960972763,3.54258814601358e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30190.Monocyte percentage,51016,-0.008249031591918,0.00392421095795178,-0.0159404850695035,-0.000557578114332522,0.0355568099463419
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30200.Neutrophill percentage,51016,0.0188616228532653,0.0038572280826989,0.0113014558111754,0.0264217898953552,1.01563595042628e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30210.Eosinophill percentage,51016,-0.00369824061067884,0.00379770267632222,-0.0111417378562704,0.0037452566349127,0.330161425523474
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30220.Basophill percentage,51016,0.0139667672122932,0.00396612469260019,0.00619316281479679,0.0217403716097896,0.000429940880796741
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30230.Nucleated red blood cell percentage,51014,-0.0346437831017111,0.12391951863023,-0.277526039616961,0.208238473413539,0.779812462363581
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30240.Reticulocyte percentage,50671,0.00676621894617259,0.00418775408243747,-0.00144177905540485,0.01497421694775,0.106170143283708
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30250.Reticulocyte count,50671,0.011151974833492,0.00422362387519265,0.00287367203811443,0.0194302776288696,0.00828712241316374
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30260.Mean reticulocyte volume,50671,0.01341108912627,0.00396457420241606,0.00564052368953447,0.0211816545630054,0.000718934710092159
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30270.Mean sphered cell volume,50671,0.00888618110876869,0.00398474190018175,0.00107608698441246,0.0166962752331249,0.0257540158735262
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30280.Immature reticulocyte fraction,50671,0.0122020269027315,0.00412675901323557,0.00411357923678978,0.0202904745686732,0.00311172381785012
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50671,0.0094765074401645,0.00424514311146132,0.00115602694170032,0.0177969879386287,0.0256039757868522
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30300.High light scatter reticulocyte count,50671,0.0131431050119877,0.00426036970128909,0.00479278039746107,0.0214934296265143,0.00203825548415225
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30500.Microalbumin in urine,36808,0.0228683622614015,0.0063516518510459,0.0104191246333515,0.0353175998894515,0.000319626955036282
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51102,-0.019245145950212,0.00427142563338752,-0.0276171401916516,-0.0108731517087725,6.65325454949643e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30520.Potassium in urine,51056,-0.0249760422307111,0.00398827693081793,-0.0327930650151142,-0.017159019446308,3.8605813793605e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30530.Sodium in urine,51071,0.000235471323233152,0.0041264318542837,-0.0078523351111629,0.0083232777576292,0.954494601983002
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30600.Albumin,48943,-0.0430085178656967,0.00422092893848282,-0.051281538585123,-0.0347354971462703,2.53105074073062e-24
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30610.Alkaline phosphatase,50625,0.0487789866000616,0.00413477269317157,0.0406748321214453,0.0568831410786779,5.03501126846079e-32
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30620.Alanine aminotransferase,50612,-0.00785730747865774,0.00448797604636339,-0.01665374052953,0.0009391255722145,0.0800035489817009
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30630.Apolipoprotein A,48882,-0.0376142899889949,0.00457265393303544,-0.0465766916977444,-0.0286518882802455,2.05256396372402e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30640.Apolipoprotein B,50469,0.0333228298094118,0.00387261297028524,0.0257325083876527,0.0409131512311708,8.15620064903308e-18
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30650.Aspartate aminotransferase,50547,0.0130020850291431,0.00413415107210382,0.00489914892781965,0.0211050211304666,0.00166283694096179
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30660.Direct bilirubin,49094,-0.0251640196154469,0.0041926908609596,-0.0333816937029277,-0.0169463455279661,1.98328542012286e-09
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30670.Urea,50609,-0.00630702916240811,0.00406371040524612,-0.0142719015566905,0.00165784323187428,0.120667734134441
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30680.Calcium,48936,-0.0127735783095195,0.00418925556612663,-0.0209845192191276,-0.00456263739991126,0.00229801319882084
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30690.Cholesterol,50628,0.0272612277245125,0.00391332324278771,0.0195911141686486,0.0349313412803764,3.34645318201609e-12
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30700.Creatinine,50615,0.0124576268223491,0.00506452279801223,0.00253116213824513,0.0223840915064531,0.0139097354235498
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30710.C-reactive protein,50549,0.0501890464679227,0.00432568479314161,0.0417107042733652,0.0586673886624803,4.92669886326176e-31
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30720.Cystatin C,50633,0.0506722055831702,0.00466672151030018,0.0415254314229818,0.0598189797433586,2.13896235088121e-27
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30730.Gamma glutamyltransferase,50611,0.010241991723274,0.00473522138566112,0.000960957807378241,0.0195230256391698,0.0305566560310678
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30740.Glucose,48910,-0.0124364689864101,0.00398722561097188,-0.020251431183915,-0.00462150678890527,0.0018167145168061
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50534,0.0272217751866582,0.00400742995432693,0.0193672124761774,0.035076337897139,1.12772369038668e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30760.HDL cholesterol,48922,-0.0368145573645297,0.00472497293839703,-0.0460755043237879,-0.0275536104052715,6.93940259908649e-15
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30770.IGF-1,50523,0.0016285957958186,0.00416061724449759,-0.00652621400339668,0.00978340559503388,0.695482268182261
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30780.LDL direct,50577,0.0323939228805809,0.00390278236473211,0.0247444694457059,0.0400433763154558,1.09849034278455e-16
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30790.Lipoprotein A,46190,0.0100838280865386,0.00429259618193078,0.00167033956995431,0.018497316603123,0.0188287877683431
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30810.Phosphate,48883,-0.0176337010074183,0.0040852137291357,-0.0256407199165243,-0.00962668209831231,1.59295650184052e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30830.SHBG,48790,0.0167984426668408,0.00544516169940021,0.00612592573601636,0.0274709595976652,0.00203812263125572
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30840.Total bilirubin,50529,-0.0242684013240187,0.00426934566263397,-0.0326363188227812,-0.0159004838252561,1.32988275097641e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30850.Testosterone,50398,0.0214218776300665,0.00671030239756636,0.00826968493083647,0.0345740703292966,0.00141302742023564
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30860.Total protein,48913,-0.0170959967077251,0.00415449962043703,-0.0252388159637817,-0.00895317745166856,3.8861258619537e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30870.Triglycerides,50601,0.0315010940145752,0.00410169071406152,0.0234617802150146,0.0395404078141357,1.65677522511907e-14
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30880.Urate,50598,0.00604293167480304,0.00491885964200056,-0.00359803322351806,0.0156838965731241,0.219263883960466
SFTPA2,Pulmonary surfactant-associated protein A2,Blood and urine assays,X30890.Vitamin D,49959,-0.0291173267479145,0.00441640616827298,-0.0377734828377296,-0.0204611706580995,4.41121886424125e-11
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3137.Number of measurements made,49364,-0.0300484091702116,0.0289017399405282,-0.0866958194536468,0.0265990011132236,0.298503143160944
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3143.Ankle spacing width,41696,0.000527827568406224,0.0071320805314041,-0.0134510502731458,0.0145067054099583,0.941005534579275
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41695,-0.0210057279961983,0.00519775746591719,-0.031193332629396,-0.0108181233630006,5.34581389869788e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3146.Speed of sound through heel,41696,-0.0231558970014234,0.00502164191069029,-0.0329983151463764,-0.0133134788564705,4.04100466184779e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41696,-0.0232311364076966,0.00506852548050735,-0.033165446349491,-0.0132968264659021,4.61680772697947e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X3148.Heel bone mineral density (BMD),41677,-0.022563378735698,0.00509449006615171,-0.0325485792653553,-0.0125781782060406,9.54497398592405e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X3526.Mother's age at death,42428,-8.85878950498907e-05,0.00521182881432519,-0.0103037723711273,0.0101265965810275,0.986438880710464
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32860,0.0107038488867247,0.00881562064455776,-0.00657476757660851,0.0279824653500579,0.224742029909716
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4100.Ankle spacing width (left),35997,-0.00623420053353682,0.00953191267413305,-0.0249167493748376,0.012448348307764,0.513109857308222
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35995,-0.0145477857256335,0.0068793013521111,-0.0280312163757713,-0.00106435507549579,0.0344873136604067
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4103.Speed of sound through heel (left),35997,-0.0158578551568359,0.0065884939484511,-0.0287713032958001,-0.00294440701787175,0.0161128638375911
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35997,-0.0159027182171198,0.00668058453358379,-0.028996663902944,-0.00280877253129555,0.0173172422220986
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35988,-0.0171242668638421,0.00670660839450701,-0.0302692193170758,-0.00397931441060831,0.0106893703238149
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35997,-0.0158901768252778,0.00668100519027453,-0.0289849469982158,-0.00279540665233967,0.0174126712225551
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4119.Ankle spacing width (right),35986,-0.00439333336879069,0.00932198322020568,-0.0226644204803938,0.0138777537428125,0.637449421625748
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35985,-0.00672881307493009,0.00693334049421669,-0.0203181604435948,0.00686053429373462,0.331828668635535
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4122.Speed of sound through heel (right),35986,-0.00909024666302975,0.0065730975088356,-0.0219735177803475,0.00379302445428803,0.166722867599802
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35986,-0.00875670773843869,0.00669030981701736,-0.0218697149797927,0.00435629950291534,0.190621039303012
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35975,-0.00828486958315109,0.00672406693337834,-0.0214640407725726,0.00489430160627045,0.217942862385609
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35986,-0.0087616330490852,0.00669030714753798,-0.0218746350582596,0.00435136896008924,0.190371577670154
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4194.Pulse rate,36371,0.00521049020696138,0.00620822587706621,-0.00695763251208838,0.0173786129260111,0.401333467335191
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4195.Pulse wave reflection index,36371,-0.000670155192727525,0.00651948260143338,-0.013448341091537,0.0121080307060819,0.918130154690593
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4196.Pulse wave peak to peak time,36363,-0.00195331049244474,0.00718195337959603,-0.016029939116453,0.0121233181315635,0.78564861166326
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4198.Position of the pulse wave peak,36371,0.0268333092084393,0.0077551066552616,0.0116333001641266,0.042033318252752,0.000542910566153348
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4199.Position of pulse wave notch,36371,0.0187234630255664,0.00628889783578463,0.00639722326742854,0.0310497027837043,0.00291767702108603
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4200.Position of the shoulder on the pulse waveform,36371,0.0232048578344763,0.00790384784245289,0.00771331606326862,0.0386963996056839,0.00333562998069135
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4269.Number of triplets attempted (left),36148,-0.0457145956389677,0.113343151583915,-0.267867172743441,0.176437981465505,0.68671755452925
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4270.Volume level set by participant (left),36060,0.0324136519944325,0.037420140648343,-0.0409298236763198,0.105757127665185,0.386403582749315
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4276.Number of triplets attempted (right),36154,0.0822233146813632,0.116100039669807,-0.145332763071459,0.309779392434185,0.478836181751119
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X4277.Volume level set by participant (right),36068,0.0775311204821712,0.0373371360389771,0.00435033384577597,0.150711907118566,0.0378804830932499
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X4288.Time to answer,36331,-0.000873966698344048,0.0074128971125693,-0.0154032450389799,0.0136553116422918,0.906151438749288
SFTPA2,Pulmonary surfactant-associated protein A2,Cognitive function,X4290.Duration screen displayed,36331,0.0123051052975399,0.00695484714460988,-0.00132639510589545,0.0259366057009753,0.0768857766583957
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X46.Hand grip strength (left),51638,-0.00693621260284969,0.00519708795934022,-0.0171225050031565,0.00325007979745713,0.182009208637743
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X47.Hand grip strength (right),51639,-0.00900604965318084,0.00512698449156436,-0.019054939256647,0.0010428399502853,0.0789996725593343
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X48.Waist circumference,51693,0.0117062051432517,0.00973230146900267,-0.00736910573599351,0.0307815160224969,0.22905838333019
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X4803.Tinnitus,36193,0.0817416980553593,0.042249423917701,-0.00106717282333459,0.164550568934053,0.0530591835313079
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X4825.Noisy workplace,36265,0.0993681903804894,0.040319168767023,0.0203426195971243,0.178393761163855,0.0137407183963274
SFTPA2,Pulmonary surfactant-associated protein A2,Working and living environment,X4836.Loud music exposure frequency,36220,0.159162786245454,0.0538526434524039,0.053611605078742,0.264713967412165,0.00313094506979265
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X49.Hip circumference,51687,-0.0188323052241792,0.00718669884211801,-0.0329182349547305,-0.00474637549362787,0.00878741625805648
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X50.Standing height,51645,-0.0179877307364791,0.00543551576856317,-0.0286413416428629,-0.00733411983009532,0.000936743002512852
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X5057.Number of older siblings,35349,0.0391644094966025,0.0400172477016597,-0.0392693959986505,0.117598214991856,0.327769132017971
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,X51.Seated height,51545,-0.0109829942769577,0.00472938045359186,-0.0202525799659977,-0.00171340858791764,0.0202260152342018
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5181.Ever had eye surgery,33820,-0.00978958296567423,0.0894178651227527,-0.18504859860627,0.165469432674921,0.912824973207403
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33809,-0.0106654654321534,0.00808994169734216,-0.0265217511589441,0.0051908202946372,0.187440719999432
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33805,-0.0103800011992674,0.0083346056999511,-0.0267158283711716,0.00595582597263672,0.21303714427581
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5190.Duration at which refractometer first shown (right),33754,-0.00686809753583018,0.0083414752564269,-0.0232173890384269,0.00948119396676655,0.410337277158893
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5193.Duration at which refractometer first shown (left),33750,-0.00472779711813376,0.00838837537147426,-0.0211690128462233,0.0117134186099558,0.573042100545697
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5199.logMAR, initial (right)",33788,-0.0359781294129116,0.0466505937008673,-0.127413293066611,0.0554570342407883,0.440608386805857
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5200.Final number of letters displayed (right),33788,-0.44516146907605,0.253344161668058,-0.941716025945443,0.0513930877933429,0.0789527435672216
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5201.logMAR, final (right)",33728,0.0079704934569644,0.00800303943534603,-0.00771546383631382,0.0236564507502426,0.319329546967414
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5202.Number of rounds to result (right),33788,-0.0838664616276795,0.0440646600324005,-0.170233195291185,0.00250027203582552,0.0570621664473083
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5206.logMAR, initial (left)",33783,0.0342244300842158,0.0465342437877312,-0.0569826877397375,0.125431547908169,0.46208803086993
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5207.Final number of letters displayed (left),33783,0.314243828053802,0.280656071474504,-0.235842072036226,0.864329728143831,0.262903819232881
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5208.logMAR, final (left)",33735,-0.000529846079037357,0.00806791503633534,-0.0163429595502546,0.0152832673921799,0.94764053840688
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5209.Number of rounds to result (left),33779,0.0263611448986602,0.0442938866433622,-0.0604548729223297,0.11317716271965,0.551774724993264
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33587,0.0198275507363874,0.00796912579042931,0.00420806418714595,0.0354470372856288,0.0128771221649433
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33587,0.0183521205441703,0.00783823201332066,0.00298918579806183,0.0337150552902788,0.0192528168714291
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5256.Corneal hysteresis (right),33587,-0.00887084743411657,0.00812966787878025,-0.0248049964765259,0.00706330160829273,0.275250923771249
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5257.Corneal resistance factor (right),33587,0.00470524292002801,0.00804149254666911,-0.0110560824714434,0.0204665683114995,0.55849310305345
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33562,0.00724506689971188,0.00806217564216078,-0.00855679735892325,0.023046931158347,0.368883199871008
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33562,0.0102663439714577,0.00796171741457947,-0.00533862216111806,0.0258713101040335,0.197297099921138
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5264.Corneal hysteresis (left),33562,0.000813423313448246,0.0080891291949229,-0.0150412699086006,0.0166681165354971,0.919905729153359
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X5265.Corneal resistance factor (left),33562,0.0100491305551175,0.00803497764102151,-0.0056994256212846,0.0257976867315197,0.21111273176167
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34447,-0.151919967582962,0.217479648027244,-0.57818007771636,0.274340142550436,0.484862353246305
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51627,0.0109361452382504,0.0211856128772135,-0.030587656001088,0.0524599464775888,0.605715340048745
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51627,0.0277725662046536,0.0246228373470419,-0.0204881949955485,0.0760333274048557,0.259365878620709
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51627,-0.0490653380081245,0.0606065871670294,-0.167854248855502,0.0697235728392532,0.41819512139903
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51627,-0.0363713353391316,0.00963505140790132,-0.0552560360986182,-0.017486634579645,0.000160474879608893
SFTPA2,Pulmonary surfactant-associated protein A2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51627,0.0219699940392636,0.00893962601386127,0.00444832705209549,0.0394916610264317,0.0139943361252503
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38690,-0.013171938319435,0.0117664794811542,-0.0362342381024972,0.00989036146362727,0.26297656572767
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38690,0.0554002560404438,0.0365482758126773,-0.0162343645524038,0.127034876633291,0.129598630858102
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38690,-0.018091748199502,0.0226793191115203,-0.0625432136580818,0.0263597172590778,0.425051722628409
SFTPA2,Pulmonary surfactant-associated protein A2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38690,0.0213929891772284,0.0136755617097828,-0.00541111177394598,0.0481970901284027,0.117773206032392
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51695,0.00980941606265877,0.0204418918163344,-0.0302566918973567,0.0498755240226742,0.631325581154741
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51695,0.00980941606265877,0.0204418918163344,-0.0302566918973567,0.0498755240226742,0.631325581154741
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51695,-0.0232572025983452,0.0149152362314921,-0.0524910656120698,0.00597666041537941,0.118941080570228
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51695,-0.0131140657708693,0.0262427023305617,-0.0645497623387701,0.0383216307970316,0.61727532970846
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51695,0.0687296430567944,0.0607038470625548,-0.050249897185813,0.187709183299402,0.257556939888615
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51695,0.0413394187415086,0.0435150252278836,-0.0439500307051433,0.12662886818816,0.342120503149642
SFTPA2,Pulmonary surfactant-associated protein A2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51695,0.0623752579381939,0.0640182624221433,-0.063100536409207,0.187851052285595,0.329900248862496
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51626,-0.00697608909626033,0.0132311360680992,-0.0329091157897347,0.018956937597214,0.598026508362883
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51626,-0.00570220479833312,0.0234953948549316,-0.051753178713999,0.0403487691173327,0.808244174322787
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51626,-0.0116305016032599,0.0121255319913738,-0.0353965443063526,0.0121355410998328,0.337480894019472
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51626,0.0349373255827109,0.0178556448766703,-5.97383755629524e-05,0.0699343895409847,0.0504001863406459
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51626,0.0184030042583057,0.0180497816936063,-0.0169745678611626,0.053780576377774,0.307943457582824
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51626,0.0549670196526743,0.0101662210351154,0.0350412264238482,0.0748928128815004,6.47883409132912e-08
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,36935,0.1412801347514,0.0194496135485029,0.103158892196334,0.179401377306466,4.09963839327973e-13
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,36935,0.0757038549550355,0.0185857040132528,0.0392758750890599,0.112131834821011,4.67949658437221e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,36935,-0.0170638323825858,0.0269846887794144,-0.0699538223902381,0.0358261576250664,0.527173983616568
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,36935,-0.0700450676230386,0.0202094874501405,-0.109655663025314,-0.0304344722207631,0.000531024666058807
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51574,0.0187902494662661,0.0360129638539578,-0.0517951596874911,0.0893756586200232,0.601840047613338
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51574,0.0449549480627663,0.044071958837612,-0.0414260912589532,0.131335987384486,0.307722521880157
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51574,0.179285615736674,0.0906200610421216,0.00167029609411609,0.356900935379233,0.0478919340211008
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51574,0.0711442843001558,0.0854071986749821,-0.0962538251028092,0.238542393703121,0.404852808992814
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51574,0.00180368394554688,0.0336066679404117,-0.0640653852176601,0.0676727531087539,0.957198217793363
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51574,-0.0054292083988,0.0395964049495486,-0.0830381620999153,0.0721797453023153,0.890942148989789
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51574,0.00656700792991573,0.0166813821520923,-0.0261285010881852,0.0392625169480167,0.693826212067637
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35471,-0.00152223720939561,0.0284924121184917,-0.0573673649616394,0.0543228905428482,0.957393998243537
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35471,0.174110002316116,0.028052061730885,0.119127961323581,0.229092043308651,5.7266790784864e-10
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35471,0.140411695898397,0.0396079296592875,0.0627801537661939,0.218043238030601,0.000395165314072278
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35471,-0.00187781150295188,0.0143084644755661,-0.0299224018750614,0.0261667788691576,0.895591030988562
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38547,-0.00778533939223992,0.0127341426609711,-0.0327442590077432,0.0171735802232634,0.540965168844462
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38547,-0.00853076700757294,0.0141323865804071,-0.0362302447051709,0.0191687106900251,0.546101804193772
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38547,0.0137881014790827,0.0124900205685352,-0.0106923388352463,0.0382685417934118,0.269650448842381
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38548,0.00348493693245934,0.0289612357734297,-0.0532790851834628,0.0602489590483815,0.904223310549171
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38548,0.0621565408253145,0.0173051559502574,0.0282384351628101,0.0960746464878189,0.000329994518485542
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38548,-0.0181057878127015,0.0314526773967595,-0.0797530355103501,0.043541459884947,0.564863636405194
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51626,0.0404050860927388,0.0262611450945711,-0.0110667582926206,0.0918769304780982,0.12391861933398
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51626,0.00869415841841905,0.0210227598442754,-0.0325104508763607,0.0498987677131988,0.679200716792614
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51626,-0.00670147909732377,0.0416764862112166,-0.0883873920713083,0.0749844338766608,0.872254223573409
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51626,-0.000950578198734587,0.0236842686125354,-0.047371744679304,0.0454705882818348,0.967985507035098
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51626,0.0199319809448531,0.0243127766498357,-0.0277210612888249,0.067585023178531,0.412330018523604
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51626,0.0587815391976051,0.0290373488820336,0.0018683353888192,0.115694743006391,0.0429464454318907
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51626,0.000537310540329719,0.00845143273461007,-0.016027497619506,0.0171021187001654,0.949308181904606
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34061,0.0621215799818035,0.0217844995356014,0.0194239608920248,0.104819199071582,0.00436573915584427
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34061,0.112542168803883,0.0261645539634684,0.0612596430354851,0.163824694572281,1.72744018814604e-05
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34061,-0.05236500982078,0.0193705886398444,-0.090331363554875,-0.014398656086685,0.00688619638077195
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34061,-0.0183732510093377,0.0171572233739003,-0.0520014088221822,0.0152549068035069,0.28427271639307
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51730,0.0323531944012332,0.010278533575895,0.012207268592479,0.0524991202099874,0.00164799381462209
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51730,0.0341747840208374,0.0335482160718548,-0.031579719479998,0.0999292875216728,0.308367161030615
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51730,0.0204544683540128,0.00904942017407392,0.00271760481282791,0.0381913318951977,0.0238114566435262
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51730,0.0128111785836463,0.00845879713001647,-0.00376806379118595,0.0293904209584786,0.129902841227382
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51730,0.000639020280175532,0.0143442284982523,-0.027475667576399,0.0287537081367501,0.964467220898851
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51730,0.0353132301232408,0.0129243069901956,0.00998158842245743,0.0606448718240242,0.00629394210113429
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51730,-0.00516256907520148,0.00911911296719297,-0.0230360304908997,0.0127108923404967,0.571313463609983
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51730,0.0652936098634414,0.030122133910881,0.00625422739811467,0.124332992328768,0.030197095163362
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,44708,-0.0282153400735493,0.00925695499074557,-0.0463589718554107,-0.010071708291688,0.00230731560791328
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,44708,0.0108827254354984,0.00909586851157415,-0.00694517684718696,0.0287106277181837,0.231539743092859
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,44708,-0.0118362698816819,0.0117784237005985,-0.0349219803348549,0.0112494405714911,0.314954706579606
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,44709,-0.0202932502533795,0.0184202496260063,-0.0563969395203519,0.0158104390135929,0.27061657485
SFTPA2,Pulmonary surfactant-associated protein A2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,44709,-0.00832264997316966,0.0103919073856366,-0.0286907884490173,0.012045488502678,0.423214090748439
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51510,-0.000860226218806982,0.00973132679473382,-0.0199336267364853,0.0182131742988713,0.929561418088425
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51510,-0.0123998620940846,0.00762628144546911,-0.0273473737272041,0.00254764953903485,0.103976563262353
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51510,-0.0147095918938993,0.00861639507807901,-0.0315977262469341,0.00217854245913557,0.0878052880036799
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51510,-0.0266495869584791,0.0131982726732023,-0.0525182013979556,-0.000780972519002509,0.0434809346771301
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51533,-0.0424080019386388,0.00821037656797215,-0.0585003400118642,-0.0263156638654134,2.42227195933805e-07
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51533,-0.0112322767949095,0.0114657418362678,-0.0337051307939944,0.0112405772041754,0.32727515757818
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51626,-0.018096555970933,0.0083798216901744,-0.0345210064836748,-0.00167210545819114,0.0308186267199364
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51626,-0.0266467584860072,0.0105200317432521,-0.0472660207027813,-0.00602749626923307,0.0113171546698325
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51626,0.00944945585123841,0.0224882121249652,-0.0346274399136933,0.0535263516161701,0.674346227760072
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51626,-0.0378695198056846,0.0206633132603072,-0.0783696137958867,0.0026305741845174,0.0668610705456989
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51626,0.025893111137635,0.0249861125500334,-0.0230796694604305,0.0748658917357006,0.300073038398501
SFTPA2,Pulmonary surfactant-associated protein A2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51626,-0.0210127493217754,0.0256907993250473,-0.0713667159988681,0.0293412173553172,0.413417317859725
SFTPA2,Pulmonary surfactant-associated protein A2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41696,-0.0232305912656908,0.00506854839094626,-0.0331649461119455,-0.0132962364194361,4.61963743123748e-06
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X864.Number of days or week walked 10+ minutes,51266,-0.0116407702756589,0.0215403635060821,-0.0538598827475797,0.030578342196262,0.588915065229053
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X874.Duration of walks,48680,0.00507130189739077,0.00389957210269703,-0.00257185942389541,0.0127144632186769,0.193452629030659
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50682,-0.043988467326884,0.0209979544713072,-0.085144458090646,-0.00283247656312198,0.0361918743394034
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X894.Duration of moderate activity,45992,0.0281634283640858,0.0250438526058781,-0.0209225227434353,0.0772493794716069,0.260789131814522
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X90087.No-wear time bias adjusted average acceleration,33204,-0.00201705806507487,0.00855101837073423,-0.018777054071714,0.0147429379415642,0.813532300810357
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50605,-0.0661178291884188,0.0215814331680536,-0.108417438197804,-0.0238182201790338,0.0021892325985956
SFTPA2,Pulmonary surfactant-associated protein A2,Physical activities,X914.Duration of vigorous activity,41750,-0.00126221302496826,0.00460418198123101,-0.010286409708181,0.00776198365824452,0.783977573229148
